Browse by Publication

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Year | Authors/Creators | Item Type | Full Text
Jump to: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001
Number of items: 343.

2017

Benn, CS; Jacobsen, LH; Fisker, AB; Rodrigues, A; Sartono, E; Lund, N; Whittle, HC; Aaby, P; (2017) Campaigns with oral polio vaccine may lower mortality and create unexpected results. Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2016.11.006
[img]

Cornick, JE; Bishop, OT; Yalcin, F; Kiran, AM; Kumwenda, B; Chaguza, C; Govindpershad, S; Ousmane, S; Senghore, M; du Plessis, M; +15 more... (2017) The global distribution and diversity of protein vaccine candidate antigens in the highly virulent Streptococcus pnuemoniae serotype 1. Vaccine, 35 (6). pp. 972-980. ISSN 0264-410X DOI: 10.1016/j.vaccine.2016.12.037 Full text not available from this repository.

Lulla, V; Losada, A; Lecollinet, S; Kerviel, A; Lilin, T; Sailleau, C; Beck, C; Zientara, S; Roy, P; (2017) Protective efficacy of multivalent replication-abortive vaccine strains in horses against African horse sickness virus challenge. Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2017.06.023 Full text not available from this repository.

Milligan, P; Flach, C; Theisen, M; (2017) Efficacy of the GMZ2 malaria vaccine in African children. Vaccine, 35 (2). p. 202. ISSN 0264-410X DOI: 10.1016/j.vaccine.2016.11.016 Full text not available from this repository.

Moberley, S; Licciardi, PV; Balloch, A; Andrews, R; Leach, AJ; Kirkwood, M; Binks, P; Mulholland, K; Carapetis, J; Tang, MLK; +1 more... (2017) Repeat pneumococcal polysaccharide vaccine in Indigenous Australian adults is associated with decreased immune responsiveness. Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2017.04.040 Full text not available from this repository.

Sundaram, N; Chen, C; Yoong, J; Luvsan, ME; Fox, K; Sarankhuu, A; La Vincente, S; Jit, M; (2017) Cost-effectiveness of 13-valent pneumococcal conjugate vaccination in Mongolia. Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2016.12.070
[img]

Titball, RW; Burtnick, MN; Bancroft, GJ; Brett, P; (2017) Burkholderia pseudomallei and Burkholderia mallei vaccines: Are we close to clinical trials? Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2017.03.022 Full text not available from this repository.

Verani, JR; Baqui, AH; Broome, CV; Cherian, T; Cohen, C; Farrar, JL; Feikin, DR; Groome, MJ; Hajjeh, RA; Johnson, HL; +15 more... (2017) Case-control vaccine effectiveness studies: Data collection, analysis and reporting results. Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2017.04.035 Full text not available from this repository.

Verani, JR; Baqui, AH; Broome, CV; Cherian, T; Cohen, C; Farrar, JL; Feikin, DR; Groome, MJ; Hajjeh, RA; Johnson, HL; +15 more... (2017) Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls. Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2017.04.037 Full text not available from this repository.

2016

Alleman, M.M. ; Wannemuehler, K.A. ; Hao, L. ; Perelygina, L. ; Icenogle, J.P. ; Vynnycky, E. ; Fwamba, F. ; Edidi, S. ; Mulumba, A. ; Sidibe, K. ; +1 more... (2016) [Accepted Manuscript] Estimating the burden of rubella virus infection and congenital rubella syndrome through a rubella immunity assessment among pregnant women in the Democratic Republic of the Congo: Potential impact on vaccination policy. Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2016.10.059 (In Press) Item availability may be restricted.
[img]

Alleman, MM; Wannemuehler, KA; Hao, L; Perelygina, L; Icenogle, JP; Vynnycky, E; Fwamba, F; Edidi, S; Mulumba, A; Sidibe, K; +1 more... (2016) Estimating the burden of rubella virus infection and congenital rubella syndrome through a rubella immunity assessment among pregnant women in the Democratic Republic of the Congo: Potential impact on vaccination policy. Vaccine, 34 (51). pp. 6502-6511. ISSN 0264-410X DOI: 10.1016/j.vaccine.2016.10.059 Full text not available from this repository.

Becker, BF; Larson, HJ; Bonhoeffer, J; van Mulligen, EM; Kors, JA; Sturkenboom, MC; (2016) Evaluation of a multinational, multilingual vaccine debate on Twitter. Vaccine, 34 (50). pp. 6166-6171. ISSN 0264-410X DOI: 10.1016/j.vaccine.2016.11.007 Full text not available from this repository.

Casey, WT; Spink, N; Cia, F; Collins, C; Romano, M; Berisio, R; Bancroft, GJ; McClean, S; (2016) Identification of an OmpW homologue in Burkholderia pseudomallei, a protective vaccine antigen against melioidosis. Vaccine, 34 (23). pp. 2616-21. ISSN 0264-410X DOI: 10.1016/j.vaccine.2016.03.088 Full text not available from this repository.

Champion, OL; Gourlay, LJ; Scott, AE; Lassaux, P; Conejero, L; Perletti, L; Hemsley, C; Prior, J; Bancroft, G; Bolognesi, M; +1 more... (2016) Immunisation with proteins expressed during chronic murine melioidosis provides enhanced protection against disease. Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2016.02.038 Full text not available from this repository.

Cutts, FT; Claquin, P; Danovaro-Holliday, MC; Rhoda, DA; (2016) Monitoring vaccination coverage: Defining the role of surveys. Vaccine, 34 (35). pp. 4103-9. ISSN 0264-410X DOI: 10.1016/j.vaccine.2016.06.053 Full text not available from this repository.

Duval, L; Wolff, FC; McKee, M; Roberts, B; (2016) The Roma vaccination gap: Evidence from twelve countries in Central and South-East Europe. Vaccine, 34 (46). pp. 5524-5530. ISSN 0264-410X DOI: 10.1016/j.vaccine.2016.10.003 Full text not available from this repository.

Fitzpatrick, MC; Wenzel, NS; Scarpino, SV; Althouse, BM; Atkins, KE; Galvani, AP; Townsend, JP; (2016) Cost-effectiveness of next-generation vaccines: The case of pertussis. Vaccine, 34 (29). pp. 3405-11. ISSN 0264-410X DOI: 10.1016/j.vaccine.2016.04.010 Full text not available from this repository.

Fowlkes, AL; Witte, D; Beeler, J; Audet, SA; Broadhead, R; Bellini, WJ; Cutts, F; Helfand, RF; (2016) Supplemental measles vaccine antibody response among HIV-infected and -uninfected children in Malawi after 1- and 2-dose primary measles vaccination schedules. Vaccine, 34 (12). pp. 1459-64. ISSN 0264-410X DOI: 10.1016/j.vaccine.2016.01.055 Full text not available from this repository.

Ghebrehewet, S; Thorrington, D; Farmer, S; Kearney, J; Blissett, D; McLeod, H; Keenan, A; (2016) The economic cost of measles: Healthcare, public health and societal costs of the 2012-13 outbreak in Merseyside, UK. Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2016.02.029 Full text not available from this repository.

Griffiths, UK; Bozzani, FM; Chansa, C; Kinghorn, A; Kalesha-Masumbu, P; Rudd, C; Chilengi, R; Brenzel, L; Schutte, C; (2016) Costs of introducing pneumococcal, rotavirus and a second dose of measles vaccine into the Zambian immunisation programme: Are expansions sustainable? Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2016.06.050 Full text not available from this repository.

Karafillakis, E. ; Dinca, I. ; Apfel, F. ; Cecconi, S. ; Wűrz, A. ; Takacs, J. ; Suk, J. ; Celentano, L.P. ; Kramarz, P. ; Larson, H.J. ; (2016) [Accepted Manuscript] Vaccine hesitancy among healthcare workers in Europe: A qualitative study. Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2016.08.029 Item availability may be restricted.
[img]

Karafillakis, E; Dinca, I; Apfel, F; Cecconi, S; Wűrz, A; Takacs, J; Suk, J; Celentano, LP; Kramarz, P; Larson, HJ; (2016) Vaccine hesitancy among healthcare workers in Europe: A qualitative study. Vaccine, 34 (41). pp. 5013-20. ISSN 0264-410X DOI: 10.1016/j.vaccine.2016.08.029 Full text not available from this repository.

Kobayashi, M; Schrag, SJ; Alderson, MR; Madhi, SA; Baker, CJ; Sobanjo-Ter Meulen, A; Kaslow, DC; Smith, PG; Moorthy, VS; Vekemans, J; (2016) WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27-28 April 2016. Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2016.12.029 Full text not available from this repository.

Miyahara, R; Jasseh, M; Gomez, P; Shimakawa, Y; Greenwood, B; Keita, K; Ceesay, S; D'Alessandro, U; Roca, A; (2016) Barriers to timely administration of birth dose vaccines in The Gambia, West Africa. Vaccine, 34 (29). pp. 3335-41. ISSN 0264-410X DOI: 10.1016/j.vaccine.2016.05.017 Full text not available from this repository.

Modjarrad, K; Giersing, B; Kaslow, DC; Smith, PG; Moorthy, VS; WHO RSV Vaccine Consultation Expert Group; , COLLABORATORS; Arora, NK; Bont, L; Campbell, H; +15 more... (2016) WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23-24 March 2015. Vaccine, 34 (2). pp. 190-7. ISSN 0264-410X DOI: 10.1016/j.vaccine.2015.05.093 Full text not available from this repository.

Paterson, P; Meurice, F; Stanberry, LR; Glismann, S; Rosenthal, SL; Larson, HJ; (2016) Vaccine hesitancy and healthcare providers. Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2016.10.042 Full text not available from this repository.

Peprah, D; Palmer, JJ; Rubin, GJ; Abubakar, A; Costa, A; Martin, S; Perea, W; Larson, HJ; (2016) Perceptions of oral cholera vaccine and reasons for full, partial and non-acceptance during a humanitarian crisis in South Sudan. Vaccine, 34 (33). pp. 3823-7. ISSN 0264-410X DOI: 10.1016/j.vaccine.2016.05.038 Full text not available from this repository.

Pond, R; Mounier-Jack, S; (2016) Comments on "Monitoring vaccination coverage: Defining the role of surveys". Vaccine, 34 (50). p. 6111. ISSN 0264-410X DOI: 10.1016/j.vaccine.2016.09.066 Full text not available from this repository.

Recker, M; Vannice, K; Hombach, J; Jit, M; Simmons, CP; (2016) Assessing dengue vaccination impact: Model challenges and future directions. Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2016.06.082 Full text not available from this repository.

Sirima, S.B.; Mordmüller, B.; Milligan, P.; Ngoa, U.A.; Kironde, F.; Atuguba, F.; Tiono, A.B.; Issifou, S.; Kaddumukasa, M.; Bangre, O.; +34 more... (2016) [Accepted Manuscript] A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children. Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2016.07.041 (In Press) Item availability may be restricted.
[img]

Sirima, SB; Mordmüller, B; Milligan, P; Ngoa, UA; Kironde, F; Atuguba, F; Tiono, AB; Issifou, S; Kaddumukasa, M; Bangre, O; +34 more... (2016) A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children. Vaccine, 34 (38). pp. 4536-42. ISSN 0264-410X DOI: 10.1016/j.vaccine.2016.07.041 Full text not available from this repository.

Steer, AC; Carapetis, JR; Dale, JB; Fraser, JD; Good, MF; Guilherme, L; Moreland, NJ; Mulholland, EK; Schodel, F; Smeesters, PR; (2016) Status of vaccine research and development of vaccines for Streptococcus pyogenes. Vaccine, 34 (26). pp. 2953-8. ISSN 0264-410X DOI: 10.1016/j.vaccine.2016.03.073 Full text not available from this repository.

Yang, J; Atkins, KE; Feng, L; Pang, M; Zheng, Y; Liu, X; Cowling, BJ; Yu, H; (2016) Seasonal influenza vaccination in China: Landscape of diverse regional reimbursement policy, and budget impact analysis. Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2016.10.013 Full text not available from this repository.

van Kleef, E; Deeny, SR; Jit, M; Cookson, B; Goldenberg, SD; Edmunds, WJ; Robotham, JV; (2016) The projected effectiveness of Clostridium difficile vaccination as part of an integrated infection control strategy. Vaccine, 34 (46). pp. 5562-5570. ISSN 0264-410X DOI: 10.1016/j.vaccine.2016.09.046 Full text not available from this repository.

2015

, WholeMycobacteriaCellVaccinesforTuberculosisSummaryGroup; (including White, RG; ); (2015) Developing whole mycobacteria cell vaccines for tuberculosis: Workshop proceedings, Max Planck Institute for Infection Biology, Berlin, Germany, July 9, 2014. [Conference or Workshop Item] Full text not available from this repository.

Ahmeti, A; Preza, I; Simaku, A; Nelaj, E; Clark, AD; Felix Garcia, AG; Lara, C; Hoestlandt, C; Blau, J; Bino, S; (2015) Cost-effectiveness of rotavirus vaccination in Albania. Vaccine, 33 Suppl 1. A201-8. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.12.075 Full text not available from this repository.

Bar-Zeev, N; Kapanda, L; King, C; Beard, J; Phiri, T; Mvula, H; Crampin, AC; Mwansambo, C; Costello, A; Parashar, U; +7 more... (2015) Methods and challenges in measuring the impact of national pneumococcal and rotavirus vaccine introduction on morbidity and mortality in Malawi. Vaccine, 33 (23). pp. 2637-45. ISSN 0264-410X DOI: 10.1016/j.vaccine.2015.04.053
[img]

Blau, J; Hoestlandt, C; D Clark, A; Baxter, L; Felix Garcia, AG; Mounaud, B; Mosina, L; (2015) Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe. Vaccine, 33 Suppl 1. A34-9. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.12.073 Full text not available from this repository.

Boelsen, LK; Dunne, EM; Lamb, KE; Bright, K; Cheung, YB; Tikoduadua, L; Russell, FM; Mulholland, EK; Licciardi, PV; Satzke, C; (2015) Long-term impact of pneumococcal polysaccharide vaccination on nasopharyngeal carriage in children following a reduced dose pneumococcal conjugate vaccine primary series in infancy. Vaccine, 33 (42). pp. 5708-14. ISSN 0264-410X DOI: 10.1016/j.vaccine.2015.07.059 Full text not available from this repository.

Bottai, D; Frigui, W; Clark, S; Rayner, E; Zelmer, A; Andreu, N; de Jonge, MI; Bancroft, GJ; Williams, A; Brodin, P; +1 more... (2015) Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system. Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2015.03.083 Full text not available from this repository.

Delrieu, I; Leboulleux, D; Ivinson, K; Gessner, BD; Malaria Transmission Blocking Vaccine Technical Consultation Gro; (2015) Design of a Phase III cluster randomized trial to assess the efficacy and safety of a malaria transmission blocking vaccine. Vaccine, 33 (13). pp. 1518-1526. ISSN 0264-410X DOI: 10.1016/j.vaccine.2015.01.050 Full text not available from this repository.

Diop, A; Atherly, D; Faye, A; Lamine Sall, F; Clark, AD; Nadiel, L; Yade, B; Ndiaye, M; Fafa Cissé, M; Ba, M; (2015) Estimated impact and cost-effectiveness of rotavirus vaccination in Senegal: A country-led analysis. Vaccine, 33 Suppl 1. A119-25. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.12.065 Full text not available from this repository.

Fletcher, H; (2015) Profiling the host immune response to tuberculosis vaccines. Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2015.07.090 Full text not available from this repository.

Irurzun-Lopez, M; Erondu, NA; Djibo, A; Griffiths, U; Stuart, JM; Fernandez, K; Ronveaux, O; Le Gargasson, JB; Gessner, BD; Colombini, A; (2015) The actual and potential costs of meningitis surveillance in the African meningitis belt: Results from Chad and Niger. Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2015.10.045 Full text not available from this repository.

Jarrett, C; Wilson, R; O'Leary, M; Eckersberger, E; Larson, HJ; SAGE Working Group on Vaccine Hesitancy; , COLLABORATORS; Eskola, J; Liang, X; Chaudhuri, M; +14 more... (2015) Strategies for addressing vaccine hesitancy - A systematic review. Vaccine, 33 (34). pp. 4180-90. ISSN 0264-410X DOI: 10.1016/j.vaccine.2015.04.040 Full text not available from this repository.

Jauregui, B; Garcia, AG; Bess Janusz, C; Blau, J; Munier, A; Atherly, D; Mvundura, M; Hajjeh, R; Lopman, B; Clark, AD; +4 more... (2015) Evidence-based decision-making for vaccine introductions: Overview of the ProVac International Working Group's experience. Vaccine, 33 Suppl 1. A28-33. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.10.090 Full text not available from this repository.

Jauregui, B; Janusz, CB; Clark, AD; Sinha, A; Garcia, AG; Resch, S; Toscano, CM; Sanderson, C; Andrus, JK; (2015) ProVac Global Initiative: a vision shaped by ten years of supporting evidence-based policy decisions. Vaccine, 33 Suppl 1. A21-7. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.12.080 Full text not available from this repository.

Javanbakht, M; Moradi-Lakeh, M; Yaghoubi, M; Esteghamati, A; Mansour Ghanaie, R; Mahmoudi, S; Shamshiri, AR; Zahraei, SM; Baxter, L; Shakerian, S; +4 more... (2015) Cost-effectiveness analysis of the introduction of rotavirus vaccine in Iran. Vaccine, 33 Suppl 1. A192-200. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.12.035 Full text not available from this repository.

Jit, M; Brewer, N; McKenzie, D; Odugleh-Kolev, A; Suisse, S; (2015) Building a new communication paradigm: Can we influence influenza perception? Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2015.08.051 Full text not available from this repository.

Jit, M; Huyen, DT; Friberg, I; Van Minh, H; Kiet, PH; Walker, N; Van Cuong, N; Duong, TN; Toda, K; Hutubessy, R; +2 more... (2015) Thirty years of vaccination in Vietnam: Impact and cost-effectiveness of the national Expanded Programme on Immunization. Vaccine, 33 Suppl 1. A233-9. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.12.017
[img]

Karafillakis, E; Hassounah, S; Atchison, C; (2015) Effectiveness and impact of rotavirus vaccines in Europe, 2006-2014. Vaccine, 33 (18). pp. 2097-107. ISSN 0264-410X DOI: 10.1016/j.vaccine.2015.03.016
[img]

Kariuki, S; Gordon, MA; Feasey, N; Parry, CM; (2015) Antimicrobial resistance and management of invasive Salmonella disease. Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2015.03.102 Full text not available from this repository.

Kaufmann, SH; Fletcher, HA; Guzman, CA; Ottenhoff, TH; (2015) Introduction and section summaries. Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2015.04.078 Full text not available from this repository.

Kieninger, MP; Caballero, EG; Sosa, AA; Amarilla, CT; Jáuregui, B; Janusz, CB; Clark, AD; Castellanos, RM; (2015) Cost-effectiveness analysis of pneumococcal conjugate vaccine introduction in Paraguay. Vaccine, 33 Suppl 1. A143-53. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.12.078 Full text not available from this repository.

King, C; Beard, J; Crampin, AC; Costello, A; Mwansambo, C; Cunliffe, NA; Heyderman, RS; French, N; Bar-Zeev, N; VacSurv Consortium; +9 more... (2015) Methodological challenges in measuring vaccine effectiveness using population cohorts in low resource settings. Vaccine, 33 (38). pp. 4748-55. ISSN 0264-410X DOI: 10.1016/j.vaccine.2015.07.062
[img]

Komakhidze, T; Hoestlandt, C; Dolakidze, T; Shakhnazarova, M; Chlikadze, R; Kopaleishvili, N; Goginashvili, K; Kherkheulidze, M; Clark, AD; Blau, J; (2015) Cost-effectiveness of pneumococcal conjugate vaccination in Georgia. Vaccine, 33 Suppl 1. A219-26. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.12.070 Full text not available from this repository.

Larson, HJ; (2015) Maternal immunization: The new "normal" (or it should be). Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2015.08.061 Full text not available from this repository.

Larson, HJ; Jarrett, C; Schulz, WS; Chaudhuri, M; Zhou, Y; Dube, E; Schuster, M; MacDonald, NE; Wilson, R; SAGE Working Group on Vaccine Hesitancy; +18 more... (2015) Measuring vaccine hesitancy: The development of a survey tool. Vaccine, 33 (34). pp. 4165-75. ISSN 0264-410X DOI: 10.1016/j.vaccine.2015.04.037 Full text not available from this repository.

Le, P; Griffiths, UK; Anh, DD; Franzini, L; Chan, W; Swint, JM; (2015) Cost-effectiveness of Haemophilus influenzae type b vaccine in Vietnam. Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2015.05.050 Full text not available from this repository.

Mezones-Holguin, E; Canelo-Aybar, C; Clark, AD; Janusz, CB; Jaúregui, B; Escobedo-Palza, S; Hernandez, AV; Vega-Porras, D; González, M; Fiestas, F; +3 more... (2015) Cost-effectiveness analysis of 10- and 13-valent pneumococcal conjugate vaccines in Peru. Vaccine, 33 Suppl 1. A154-66. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.12.039 Full text not available from this repository.

Novaes, HM; de Soárez, PC; Silva, GA; Ayres, A; Itria, A; Rama, CH; Sartori, AM; Clark, AD; Resch, S; (2015) Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil. Vaccine, 33 Suppl 1. A135-42. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.12.031 Full text not available from this repository.

Nyiro, JU; Sande, C; Mutunga, M; Kiyuka, PK; Munywoki, PK; Scott, JA; Nokes, DJ; (2015) Quantifying maternally derived respiratory syncytial virus specific neutralising antibodies in a birth cohort from coastal Kenya. Vaccine, 33 (15). pp. 1797-801. ISSN 0264-410X DOI: 10.1016/j.vaccine.2015.02.039
[img]

Portnoy, A; Jit, M; Lauer, J; Blommaert, A; Ozawa, S; Stack, M; Murray, J; Hutubessy, R; (2015) Estimating costs of care for meningitis infections in low- and middle-income countries. Vaccine, 33 Suppl 1. A240-7. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.11.061 Full text not available from this repository.

Roca, A; Bojang, A; Bottomley, C; Gladstone, RA; Adetifa, JU; Egere, U; Burr, S; Antonio, M; Bentley, S; Kampmann, B; +8 more... (2015) Effect on nasopharyngeal pneumococcal carriage of replacing PCV7 with PCV13 in the Expanded Programme of Immunization in the Gambia. Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2015.11.012 Full text not available from this repository.

Sander, P; Clark, S; Petrera, A; Vilaplana, C; Meuli, M; Selchow, P; Zelmer, A; Mohanan, D; Andreu, N; Rayner, E; +6 more... (2015) Deletion of zmp1 improves Mycobacterium bovis BCG-mediated protection in a guinea pig model of tuberculosis. Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2015.01.058 Full text not available from this repository.

Sanderson, CF; (2015) The ProVac initiative and evolving decision support. Vaccine, 33 Suppl 1. A8-A10. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.12.049 Full text not available from this repository.

Seale, AC; Barsosio, HC; Koech, AC; Berkley, JA; KIPMAT group; (2015) Embedding surveillance into clinical care to detect serious adverse events in pregnancy. Vaccine, 33 (47). pp. 6466-8. ISSN 0264-410X DOI: 10.1016/j.vaccine.2015.07.086
[img]

Sibak, M; Moussa, I; El-Tantawy, N; Badr, S; Chaudhri, I; Allam, E; Baxter, L; Abo Freikha, S; Hoestlandt, C; Lara, C; +2 more... (2015) Cost-effectiveness analysis of the introduction of the pneumococcal conjugate vaccine (PCV-13) in the Egyptian national immunization program, 2013. Vaccine, 33 Suppl 1. A182-91. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.12.044 Full text not available from this repository.

Sigei, C; Odaga, J; Mvundura, M; Madrid, Y; Clark, AD; Kenya ProVac Technical Working Group; Uganda ProVac Technical Working Group; (2015) Cost-effectiveness of rotavirus vaccination in Kenya and Uganda. Vaccine, 33 Suppl 1. A109-18. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.12.079 Full text not available from this repository.

Singh, SK; Roeffen, W; Andersen, G; Bousema, T; Christiansen, M; Sauerwein, R; Theisen, M; (2015) A Plasmodium falciparum 48/45 single epitope R0.6C subunit protein elicits high levels of transmission blocking antibodies. Vaccine, 33 (16). pp. 1981-6. ISSN 0264-410X DOI: 10.1016/j.vaccine.2015.02.040 Full text not available from this repository.

Thompson, CN; Tu, LT; Anders, KL; Hieu, NT; Vi, LL; Chau, NV; Duong, VT; Chau, NN; Chau, TT; Tuyen, HT; +11 more... (2015) The transfer and decay of maternal antibody against Shigella sonnei in a longitudinal cohort of Vietnamese infants. Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2015.12.047
[img]

Toh, ZQ; Licciardi, PV; Fong, J; Garland, SM; Tabrizi, SN; Russell, FM; Mulholland, EK; (2015) Reduced dose human papillomavirus vaccination: An update of the current state-of-the-art. Vaccine, 33 (39). pp. 5042-50. ISSN 0264-410X DOI: 10.1016/j.vaccine.2015.07.102 Full text not available from this repository.

Trotter, CL; Cibrelus, L; Fernandez, K; Lingani, C; Ronveaux, O; Stuart, JM; (2015) Response thresholds for epidemic meningitis in sub-Saharan Africa following the introduction of MenAfriVac(®). Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2015.09.107 Full text not available from this repository.

Vučina, VV; Filipović, SK; Kožnjak, N; Stamenić, V; Clark, AD; Mounaud, B; Blau, J; Hoestlandt, C; Kaić, B; (2015) Cost-effectiveness of pneumococcal conjugate vaccination in Croatia. Vaccine, 33 Suppl 1. A209-18. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.12.043 Full text not available from this repository.

Walwyn, L; Janusz, CB; Clark, AD; Prieto, E; Waight, E; Largaespada, N; (2015) Cost-effectiveness of HPV vaccination in Belize. Vaccine, 33 Suppl 1. A174-81. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.12.042 Full text not available from this repository.

de Francisco Shapovalova, N; Donadel, M; Jit, M; Hutubessy, R; (2015) A systematic review of the social and economic burden of influenza in low- and middle-income countries. Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2015.10.066 Full text not available from this repository.

2014

Barreto, ML; Pilger, D; Pereira, SM; Genser, B; Cruz, AA; Cunha, SS; Sant'Anna, C; Hijjar, MA; Ichihara, MY; Rodrigues, LC; (2014) Causes of variation in BCG vaccine efficacy: Examining evidence from the BCG REVAC cluster randomized trial to explore the masking and the blocking hypotheses. Vaccine, 32 (30). pp. 3759-64. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.05.042 Full text not available from this repository.

Burchett, HE; Mounier-Jack, S; Torres-Rueda, S; Griffiths, UK; Ongolo-Zogo, P; Rulisa, S; Edengue, JM; Chavez, E; Kitaw, Y; Molla, M; +5 more... (2014) The impact of introducing new vaccines on the health system: Case studies from six low- and middle-income countries. Vaccine, 32 (48). pp. 6505-12. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.09.031 Full text not available from this repository.

Dutruel, C; Thole, J; Geels, M; Mollenkopf, HJ; Ottenhoff, T; Guzman, CA; Fletcher, HA; Leroy, O; Kaufmann, SH; (2014) TRANSVAC workshop on standardisation and harmonisation of analytical platforms for HIV, TB and malaria vaccines: 'How can big data help?'. Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.06.014 Full text not available from this repository.

Hawkes, S; Kismödi, E; Larson, H; Buse, K; (2014) Vaccines to promote and protect sexual health: Policy challenges and opportunities. Vaccine, 32 (14). pp. 1610-5. ISSN 0264-410X DOI: 10.1016/j.vaccine.2013.09.039 Full text not available from this repository.

Ichihara, MY; Rodrigues, LC; Teles Santos, CA; Teixeira, MdaG; De Jesus, SR; Alvim De Matos, SM; Gagliardi Leite, JP; Barreto, ML; (2014) Effectiveness of rotavirus vaccine against hospitalized rotavirus diarrhea: A case-control study. Vaccine, 32 (23). pp. 2740-7. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.01.007 Full text not available from this repository.

Jit, M; Choi, YH; Laprise, JF; Boily, MC; Drolet, M; Brisson, M; (2014) Two-dose strategies for human papillomavirus vaccination: How well do they need to protect? Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.03.098 Full text not available from this repository.

Kanai, Y; van Rijn, PA; Maris-Veldhuis, M; Kaname, Y; Athmaram, TN; Roy, P; (2014) Immunogenicity of recombinant VP2 proteins of all nine serotypes of African horse sickness virus. Vaccine, 32 (39). pp. 4932-7. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.07.031
[img]

Keller-Stanislawski, B; Englund, JA; Kang, G; Mangtani, P; Neuzil, K; Nohynek, H; Pless, R; Lambach, P; Zuber, P; (2014) Safety of immunization during pregnancy: A review of the evidence of selected inactivated and live attenuated vaccines. Vaccine, 32 (52). pp. 7057-64. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.09.052 Full text not available from this repository.

Lamb, KE; Flasche, S; Diggle, M; Inverarity, D; Greenhalgh, D; Jefferies, JM; Smith, A; Edwards, GF; Denham, B; McMenamin, J; +4 more... (2014) Trends in serotypes and sequence types among cases of invasive pneumococcal disease in Scotland, 1999-2010. Vaccine, 32 (34). pp. 4356-63. ISSN 0264-410X DOI: 10.1016/j.vaccine.2013.05.079 Full text not available from this repository.

Laprise, JF; Drolet, M; Boily, MC; Jit, M; Sauvageau, C; Franco, EL; Lemieux-Mellouki, P; Malagón, T; Brisson, M; (2014) Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: A transmission-dynamic modelling study. Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.07.099 Full text not available from this repository.

Licciardi, PV; Russell, FM; Balloch, A; Burton, RL; Nahm, MH; Gilbert, G; Tang, ML; Mulholland, EK; (2014) Impaired serotype-specific immune function following pneumococcal vaccination in infants with prior carriage. Vaccine, 32 (20). pp. 2321-7. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.02.064 Full text not available from this repository.

Mackenzie, GA; Bottomley, C; van Hoek, AJ; Jeffries, D; Ota, M; Zaman, SM; Greenwood, B; Cutts, F; (2014) Efficacy of different pneumococcal conjugate vaccine schedules against pneumonia, hospitalisation, and mortality: Re-analysis of a randomised trial in The Gambia. Vaccine, 32 (21). pp. 2493-500. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.02.081 Full text not available from this repository.

Marsh, K; Chapman, R; Baggaley, RF; Largeron, N; Bresse, X; (2014) Mind the gaps: What's missing from current economic evaluations of universal HPV vaccination? Vaccine, 32 (30). pp. 3732-9. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.05.007 Full text not available from this repository.

Rid, A; Saxena, A; Baqui, AH; Bhan, A; Bines, J; Bouesseau, MC; Caplan, A; Colgrove, J; Dhai, A; Gomez-Diaz, R; +12 more... (2014) Placebo use in vaccine trials: Recommendations of a WHO expert panel. Vaccine, 32 (37). pp. 4708-12. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.04.022
[img]

Theisen, M; Roeffen, W; Singh, SK; Andersen, G; Amoah, L; van de Vegte-Bolmer, M; Arens, T; Tiendrebeogo, RW; Jones, S; Bousema, T; +4 more... (2014) A multi-stage malaria vaccine candidate targeting both transmission and asexual parasite life-cycle stages. Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.03.020 Full text not available from this repository.

Usuf, E; Mackenzie, G; Lowe-Jallow, Y; Boye, B; Atherly, D; Suraratdecha, C; Griffiths, UK; (2014) Costs of vaccine delivery in the Gambia before and after, pentavalent and pneumococcal conjugate vaccine introductions. Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.01.045 Full text not available from this repository.

2013

Alvar, J; Croft, SL; Kaye, P; Khamesipour, A; Sundar, S; Reed, SG; (2013) Case study for a vaccine against leishmaniasis. Vaccine, 31. B244-B249. ISSN 0264-410X DOI: 10.1016/j.vaccine.2012.11.080 Full text not available from this repository.

Arora, NK; Lal, AA; Hombach, JM; Santos, JI; Bhutta, ZA; Sow, SO; Greenwood, B; (2013) The need for targeted implementation research to improve coverage of basic vaccines and introduction of new vaccines. Vaccine, 31. B129-B136. ISSN 0264-410X DOI: 10.1016/j.vaccine.2013.01.058 Full text not available from this repository.

Asiki, G; Abaasa, A; Ruzagira, E; Kibengo, F; Bahemuka, U; Mulondo, J; Seeley, J; Bekker, LG; Delany, S; Kaleebu, P; +1 more... (2013) Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in Uganda. Vaccine, 31 (44). pp. 5055-5061. ISSN 0264-410X DOI: 10.1016/j.vaccine.2013.08.080 Full text not available from this repository.

Bentsi-Enchill, AD; Schmitz, J; Edelman, R; Durbin, A; Roehrig, JT; Smith, PG; Hombach, J; Farrar, J; Live Dengue Vaccines, Tech; (2013) Long-term safety assessment of live attenuated tetravalent dengue vaccines: Deliberations from a WHO technical consultation. Vaccine, 31 (23). pp. 2603-2609. ISSN 0264-410X DOI: 10.1016/j.vaccine.2013.03.038 Full text not available from this repository.

Choi, HC; Leung, GM; Woo, PP; Jit, M; Wu, JT; (2013) Acceptability and uptake of female adolescent HPV vaccination in Hong Kong: a survey of mothers and adolescents. Vaccine, 32 (1). pp. 78-84. ISSN 0264-410X DOI: 10.1016/j.vaccine.2013.10.068 Full text not available from this repository.

Clark, A; Jauregui, B; Griffiths, U; Janusz, CB; Bolaños-Sierra, B; Hajjeh, R; Andrus, JK; Sanderson, C; (2013) TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination. Vaccine, 31 Suppl 3. C19-29. ISSN 0264-410X DOI: 10.1016/j.vaccine.2013.05.045 Full text not available from this repository.

Dale, JB; Fischetti, VA; Carapetis, JR; Steer, AC; Sow, S; Kumar, R; Mayosi, BM; Rubin, FA; Mulholland, K; Hombach, JM; +2 more... (2013) Group A streptococcal vaccines: Paving a path for accelerated development. Vaccine, 31. B216-B222. ISSN 0264-410X DOI: 10.1016/j.vaccine.2012.09.045 Full text not available from this repository.

Dunne, EM; Smith-Vaughan, HC; Robins-Browne, RM; Mulholland, EK; Satzke, C; (2013) Nasopharyngeal microbial interactions in the era of pneumococcal conjugate vaccination. Vaccine, 31 (19). pp. 2333-2342. ISSN 0264-410X DOI: 10.1016/j.vaccine.2013.03.024 Full text not available from this repository.

Fesenfeld, M; Hutubessy, R; Jit, M; (2013) Cost-effectiveness of human papillomavirus vaccination in low and middle income countries: A systematic review. Vaccine, 31 (37). pp. 3786-804. ISSN 0264-410X DOI: 10.1016/j.vaccine.2013.06.060 Full text not available from this repository.

Hotez, PJ; Diemert, D; Bacon, KM; Beaumier, C; Bethony, JM; Bottazzi, ME; Brooker, S; Couto, AR; Freire, MD; Homma, A; +6 more... (2013) The Human Hookworm Vaccine. Vaccine, 31. B227-B232. ISSN 0264-410X DOI: 10.1016/j.vaccine.2012.11.034
[img]

Mesher, D; Soldan, K; Howell-Jones, R; Panwar, K; Manyenga, P; Jit, M; Beddows, S; Gill, ON; (2013) Reduction in HPV 16/18 prevalence in sexually active young women following the introduction of HPV immunisation in England. Vaccine, 32 (1). pp. 26-32. ISSN 0264-410X DOI: 10.1016/j.vaccine.2013.10.085
[img]

Meyer, J; Harris, SA; Satti, I; Poulton, ID; Poyntz, HC; Tanner, R; Rowland, R; Griffiths, KL; Fletcher, HA; McShane, H; (2013) Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery. Vaccine, 31 (7). pp. 1026-33. ISSN 0264-410X DOI: 10.1016/j.vaccine.2012.12.042 Full text not available from this repository.

Sanz-Ramos, M; Manno, D; Kapambwe, M; Ndumba, I; Musonda, KG; Bates, M; Chibumbya, J; Siame, J; Monze, M; Filteau, S; +2 more... (2013) Reduced Poliovirus vaccine neutralising-antibody titres in infants with maternal HIV-exposure. Vaccine, 31 (16). pp. 2042-9. ISSN 0264-410X DOI: 10.1016/j.vaccine.2013.02.044
[img]

Satzke, C; Turner, P; Virolainen-Julkunen, A; Adrian, PV; Antonio, M; Hare, KM; Henao-Restrepo, AM; Leach, AJ; Klugman, KP; Porter, BD; +5 more... (2013) Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization Pneumococcal Carriage Working Group. Vaccine, 32 (1). pp. 165-79. ISSN 0264-410X DOI: 10.1016/j.vaccine.2013.08.062 Full text not available from this repository.

Stewart, M; Dubois, E; Sailleau, C; Bréard, E; Viarouge, C; Desprat, A; Thiéry, R; Zientara, S; Roy, P; (2013) Bluetongue virus serotype 8 virus-like particles protect sheep against virulent virus infection as a single or multi-serotype cocktail immunogen. Vaccine, 31 (3). pp. 553-8. ISSN 0264-410X DOI: 10.1016/j.vaccine.2012.11.016 Full text not available from this repository.

Toscano, CM; Jauregui, B; Janusz, CB; Sinha, A; Clark, AD; Sanderson, C; Resch, S; Matus, CR; Andrus, JK; Provac Network Ctr, Excellence; (2013) Establishing a regional network of academic centers to support decision making for new vaccine introduction in Latin America and the Caribbean: The ProVac experience. Vaccine, 31. C12-C18. ISSN 0264-410X DOI: 10.1016/j.vaccine.2013.05.033 Full text not available from this repository.

Wang, SA; Hyde, TB; Mounier-Jack, S; Brenzel, L; Favin, M; Gordon, WS; Shearer, JC; Mantel, CF; Arora, N; Durrheim, D; (2013) New vaccine introductions: Assessing the impact and the opportunities for immunization and health systems strengthening. Vaccine, 31. B122-B128. ISSN 0264-410X DOI: 10.1016/j.vaccine.2012.10.116 Full text not available from this repository.

2012

Arbyn, M; Ronco, G; Anttila, A; Meijer, CJ; Poljak, M; Ogilvie, G; Koliopoulos, G; Naucler, P; Sankaranarayanan, R; Peto, J; (2012) Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine, 30 Suppl 5 (SUPPL.5). F88-99. ISSN 0264-410X DOI: 10.1016/j.vaccine.2012.06.095 Full text not available from this repository.

Betsch, C; Brewer, NT; Brocard, P; Davies, P; Gaissmaier, W; Haase, N; Leask, J; Renkewitz, F; Renner, B; Reyna, VF; +5 more... (2012) Opportunities and challenges of Web 2.0 for vaccination decisions. Vaccine, 30 (25). pp. 3727-33. ISSN 0264-410X DOI: 10.1016/j.vaccine.2012.02.025 Full text not available from this repository.

Burnett, RJ; Larson, HJ; Moloi, MH; Tshatsinde, EA; Meheus, A; Paterson, P; François, G; (2012) Addressing public questioning and concerns about vaccination in South Africa: a guide for healthcare workers. Vaccine, 30 Suppl 3. C72-8. ISSN 0264-410X DOI: 10.1016/j.vaccine.2012.03.037 Full text not available from this repository.

Choi, YH; Chapman, R; Gay, N; Jit, M; (2012) Potential overestimation of HPV vaccine impact due to unmasking of non-vaccine types: Quantification using a multi-type mathematical model. Vaccine, 30 (23). pp. 3383-3388. ISSN 0264-410X DOI: 10.1016/j.vaccine.2012.03.065 Full text not available from this repository.

Greenland, K; Whelan, J; Fanoy, E; Borgert, M; Hulshof, K; Yap, KB; Swaan, C; Donker, T; van Binnendijk, R; de Melker, H; +1 more... (2012) Mumps outbreak among vaccinated university students associated with a large party, the Netherlands, 2010. Vaccine, 30 (31). pp. 4676-80. ISSN 0264-410X DOI: 10.1016/j.vaccine.2012.04.083 Full text not available from this repository.

Greenwood, B; Chiarot, E; Maclennan, CA; O'Ryan, M; (2012) Can we defeat meningococcal disease in low and middle income countries? Vaccine, 30 Suppl 2. B63-6. ISSN 0264-410X DOI: 10.1016/j.vaccine.2011.12.063 Full text not available from this repository.

Jauneikaite, E; Jefferies, JM; Hibberd, ML; Clarke, SC; (2012) Prevalence of Streptococcus pneumoniae serotypes causing invasive and non-invasive disease in South East Asia: a review. Vaccine, 30 (24). pp. 3503-14. ISSN 0264-410X DOI: 10.1016/j.vaccine.2012.03.066 Full text not available from this repository.

Njie-Jobe, J; Nyamweya, S; Miles, DJC; van der Sande, M; Zaman, S; Touray, E; Hossin, S; Adetifa, J; Palmero, M; Burl, S; +5 more... (2012) Immunological impact of an additional early measles vaccine in Gambian children: Responses to a boost at 3 years. Vaccine, 30 (15). pp. 2543-2550. ISSN 0264-410X DOI: 10.1016/j.vaccine.2012.01.083
[img]

Pathan, AA; Minassian, AM; Sander, CR; Rowland, R; Porter, DW; Poulton, ID; Hill, AV; Fletcher, HA; McShane, H; (2012) Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults. Vaccine, 30 (38). pp. 5616-24. ISSN 0264-410X DOI: 10.1016/j.vaccine.2012.06.084
[img]

Stewart, M; Dovas, CI; Chatzinasiou, E; Athmaram, TN; Papanastassopoulou, M; Papadopoulos, O; Roy, P; (2012) Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: Presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection. Vaccine, 30 (12). pp. 2131-9. ISSN 0264-410X Full text not available from this repository.

Stewart, M; Dovas, CI; Chatzinasiou, E; Athmaram, TN; Papanastassopoulou, M; Papadopoulos, O; Roy, P; (2012) Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: Presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection. Vaccine, 30 (12). pp. 2131-9. ISSN 0264-410X DOI: 10.1016/j.vaccine.2012.01.042 Full text not available from this repository.

van Hoek, AJ; Choi, YH; Trotter, C; Miller, E; Jit, M; (2012) The cost-effectiveness of a 13-valent pneumococcal conjugate vaccination for infants in England. Vaccine, 30 (50). pp. 7205-7213. ISSN 0264-410X DOI: 10.1016/j.vaccine.2012.10.017 Full text not available from this repository.

2011

Barreto, ML; Pereira, SM; Pilger, D; Cruz, AA; Cunha, SS; Sant'Anna, C; Ichihara, MY; Genser, B; Rodrigues, LC; (2011) Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: Second report of the BCG-REVAC cluster-randomised trial. Vaccine, 29 (31). pp. 4875-4877. ISSN 0264-410X DOI: 10.1016/j.vaccine.2011.05.023 Full text not available from this repository.

Canfell, K; Shi, JF; Lew, JB; Walker, R; Zhao, FH; Simonella, L; Chen, JF; Legood, R; Smith, MA; Nickson, C; +1 more... (2011) Prevention of cervical cancer in rural China: Evaluation of HPV vaccination and primary HPV screening strategies. Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2010.12.085 Full text not available from this repository.

Chapman, R; Soldan, K; Jit, M; (2011) Modelling borderline and mild dysplasia associated with HPV 6 and 11 infection. Vaccine, 29 (16). pp. 2881-6. ISSN 0264-410X DOI: 10.1016/j.vaccine.2011.02.008 Full text not available from this repository.

Flanagan, KL; Klein, SL; Skakkebaek, NE; Marriott, I; Marchant, A; Selin, L; Fish, EN; Prentice, AM; Whittle, H; Benn, CS; +1 more... (2011) Sex differences in the vaccine-specific and non-targeted effects of vaccines. Vaccine, 29 (13). pp. 2349-2354. ISSN 0264-410X DOI: 10.1016/j.vaccine.2011.01.071 Full text not available from this repository.

Heymann, DL; Brilliant, L; (2011) Surveillance in eradication and elimination of infectious diseases: A progression through the years. Vaccine, 29 Suppl 4. D141-4. ISSN 0264-410X DOI: 10.1016/j.vaccine.2011.12.135 Full text not available from this repository.

Jauregui, B; Sinha, A; Clark, AD; Bolanos, BM; Resch, S; Toscano, CM; Matus, CR; Andrus, JK; (2011) Strengthening the technical capacity at country-level to make informed policy decisions on new vaccine introduction: Lessons learned by PAHO's ProVac Initiative. Vaccine, 29 (5). pp. 1099-1106. ISSN 0264-410X DOI: 10.1016/j.vaccine.2010.11.075 Full text not available from this repository.

Jit, M; Bilcke, J; Mangen, MJJ; Salo, H; Melliez, H; Edmunds, WJ; Yazdanpanah, Y; Beutels, P; (2011) Response to comment on article by Jit et al. "The cost effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe". Vaccine, 29 (21). pp. 3732-3733. ISSN 0264-410X DOI: 10.1016/j.vaccine.2011.02.104 Full text not available from this repository.

Jit, M; Yuzbashyan, R; Sahakyan, G; Avagyan, T; Mosina, L; (2011) The cost-effectiveness of rotavirus vaccination in Armenia. Vaccine, 29 (48). pp. 9104-11. ISSN 0264-410X DOI: 10.1016/j.vaccine.2011.08.127 Full text not available from this repository.

Klugman, KP; Madhi, SA; Adegbola, RA; Cutts, F; Greenwood, B; Hausdorff, WP; (2011) Timing of serotype 1 pneumococcal disease suggests the need for evaluation of a booster dose. Vaccine, 29 (18). pp. 3372-3. ISSN 0264-410X DOI: 10.1016/j.vaccine.2011.02.089 Full text not available from this repository.

Konstantyner, T; Taddei, J; Rodrigues, LC; (2011) Risk factors for incomplete vaccination in children less than 18 months of age attending the nurseries of day-care centres in Sao Paulo, Brazil. Vaccine, 29 (50). pp. 9298-9302. ISSN 0264-410X DOI: 10.1016/j.vaccine.2011.10.020 Full text not available from this repository.

Lee, H; Cho, SN; Kim, HJ; Anh, YM; Choi, JE; Kim, CH; Ock, PJ; Oh, SH; Kim, DR; Floyd, S; +1 more... (2011) Evaluation of cell-mediated immune responses to two BCG vaccination regimes in young children in South Korea. Vaccine, 29 (38). pp. 6564-71. ISSN 0264-410X DOI: 10.1016/j.vaccine.2011.07.003 Full text not available from this repository.

Russell, FM; Balloch, A; Licciardi, PV; Carapetis, JR; Tikoduadua, L; Waqatakirewa, L; Cheung, YB; Mulholland, EK; Tang, ML; (2011) Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months. Vaccine, 29 (27). pp. 4499-506. ISSN 0264-410X DOI: 10.1016/j.vaccine.2011.04.038 Full text not available from this repository.

Russell, FM; Carapetis, JR; Burton, RL; Lin, J; Licciardi, PV; Balloch, A; Tikoduadua, L; Waqatakirewa, L; Cheung, YB; Tang, MLK; +2 more... (2011) Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of age. Vaccine, 29 (3). pp. 535-544. ISSN 0264-410X DOI: 10.1016/j.vaccine.2010.10.046 Full text not available from this repository.

Scott, P; Rutjes, AW; Bermetz, L; Robert, N; Scott, S; Lourenço, T; Egger, M; Low, N; (2011) Comparing pneumococcal conjugate vaccine schedules based on 3 and 2 primary doses: Systematic review and meta-analysis. Vaccine, 29 (52). pp. 9711-21. ISSN 0264-410X DOI: 10.1016/j.vaccine.2011.07.042 Full text not available from this repository.

Tilson, L; Jit, M; Schmitz, S; Walsh, C; Garvey, P; McKeown, P; Barry, M; (2011) Cost-effectiveness of universal rotavirus vaccination in reducing rotavirus gastroenteritis in Ireland. Vaccine, 29 (43). pp. 7463-73. ISSN 0264-410X DOI: 10.1016/j.vaccine.2011.07.056 Full text not available from this repository.

Uruena, A; Pippo, T; Betelu, MS; Virgilio, F; Giglio, N; Gentile, A; Jimenez, SG; Jauregui, B; Clark, AD; Diosque, M; +1 more... (2011) Cost-effectiveness analysis of the 10-and 13-valent pneumococcal conjugate vaccines in Argentina. Vaccine, 29 (31). pp. 4963-4972. ISSN 0264-410X DOI: 10.1016/j.vaccine.2011.04.111 Full text not available from this repository.

van Hoek, AJ; Melegaro, A; Zagheni, E; Edmunds, WJ; Gay, N; (2011) Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England. Vaccine, 29 (13). pp. 2411-2420. ISSN 0264-410X DOI: 10.1016/j.vaccine.2011.01.037 Full text not available from this repository.

2010

Baguelin, M; van Hoek, AJ; Jit, M; Flasche, S; White, PJ; Edmunds, WJ; (2010) Vaccination against pandemic influenza A/H1N1v in England: A real-time economic evaluation. Vaccine, 28 (12). pp. 2370-2384. ISSN 0264-410X DOI: 10.1016/j.vaccine.2010.01.002 Full text not available from this repository.

Choi, YH; Jit, M; Gay, N; Cox, A; Garnett, GP; Edmunds, WJ; (2010) Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United Kingdom. Vaccine, 28 (24). pp. 4091-102. ISSN 0264-410X DOI: 10.1016/j.vaccine.2009.09.125 Full text not available from this repository.

Elliott, AM; Mawa, PA; Webb, EL; Nampijja, M; Lyadda, N; Bukusuba, J; Kizza, M; Namujju, PB; Nabulime, J; Ndibazza, J; +2 more... (2010) Effects of maternal and infant co-infections, and of maternal immunisation, on the infant response to BCG and tetanus immunisation. Vaccine, 29 (2). pp. 247-55. ISSN 0264-410X DOI: 10.1016/j.vaccine.2010.10.047
[img]

Hajjeh, RA; Privor-Dumm, L; Edmond, K; O'Loughlin, R; Shetty, S; Griffiths, UK; Bear, AP; Cohen, AL; Chandran, A; Schuchat, A; +2 more... (2010) Supporting new vaccine introduction decisions: Lessons learned from the Hib Initiative experience. Vaccine, 28 (43). pp. 7123-7129. ISSN 0264-410X DOI: 10.1016/j.vaccine.2010.07.028 Full text not available from this repository.

Hall, AJ; (2010) The United Kingdom Joint Committee on Vaccination and Immunisation. Vaccine, 28. A54-A57. ISSN 0264-410X DOI: 10.1016/j.vaccine.2010.02.034 Full text not available from this repository.

Hall, AJ; (2010) The United Kingdom Joint Committee on Vaccination and Immunisation. Vaccine, 28S1. A54-A57. ISSN 0264-410X DOI: 10.1016/j.vaccine.2010.02.034 Full text not available from this repository.

Hanquet, G; Perrocheau, A; Kissling, E; Bruhl, DL; Tarragó, D; Stuart, J; Stefanoff, P; Heuberger, S; Kriz, P; Vergison, A; +4 more... (2010) Surveillance of invasive pneumococcal disease in 30 EU countries: Towards a European system? Vaccine, 28 (23). pp. 3920-8. ISSN 0264-410X DOI: 10.1016/j.vaccine.2010.03.069 Full text not available from this repository.

Jit, M; Mangen, MJJ; Melliez, H; Yazdanpanah, Y; Bilcke, J; Salo, H; Edmunds, WJ; Beutels, P; (2010) An update to "The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe". Vaccine, 28 (47). pp. 7457-7459. ISSN 0264-410X DOI: 10.1016/j.vaccine.2010.08.060 Full text not available from this repository.

Kanai, Y; Boonsathorn, N; Chittaganpitch, M; Bai, G; Li, Y; Kase, T; Takahashi, K; Okuno, Y; Jampangern, W; Ikuta, K; +1 more... (2010) The impact of antigenic drift of influenza A virus on human herd immunity: Sero-epidemiological study of H1N1 in healthy Thai population in 2009. Vaccine, 28 (33). pp. 5437-44. ISSN 0264-410X DOI: 10.1016/j.vaccine.2010.06.002 Full text not available from this repository.

Ladhani, S; Heath, PT; Aibara, RJ; Ramsay, ME; Slack, MP; Hibberd, ML; Pollard, AJ; Moxon, ER; Booy, R; (2010) Long-term complications and risk of other serious infections following invasive Haemophilus influenzae serotype b disease in vaccinated children. Vaccine, 28 (10). pp. 2195-200. ISSN 0264-410X DOI: 10.1016/j.vaccine.2009.12.057 Full text not available from this repository.

Licciardi, PV; Balloch, A; Russell, FM; Mulholland, EK; Tang, MLK; (2010) Antibodies to serotype 9V exhibit novel serogroup cross-reactivity following infant pneumococcal immunization. Vaccine, 28 (22). pp. 3793-3800. ISSN 0264-410X DOI: 10.1016/j.vaccine.2010.03.033 Full text not available from this repository.

Moberley, S; Krause, V; Cook, H; Mulholland, K; Carapetis, J; Torzillo, P; Andrews, R; (2010) Failure to vaccinate or failure of vaccine? Effectiveness of the 23-valent pneumococcal polysaccharide vaccine program in Indigenous adults in the Northern Territory of Australia. Vaccine, 28 (11). pp. 2296-2301. ISSN 0264-410X DOI: 10.1016/j.vaccine.2009.12.066 Full text not available from this repository.

Mordmuller, B; Szywon, K; Greutelaers, B; Esen, M; Mewono, L; Treut, C; Murbeth, RE; Chilengi, R; Noor, R; Kilama, WL; +9 more... (2010) Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambarene, Gabon. Vaccine, 28 (41). pp. 6698-6703. ISSN 0264-410X DOI: 10.1016/j.vaccine.2010.07.085 Full text not available from this repository.

Ojo, LR; O'Loughlin, RE; Cohen, AL; Loo, JD; Edmond, KM; Shetty, SS; Bear, AP; Privor-Dumm, L; Griffiths, UK; Hajjeh, R; (2010) Global use of Haemophilus influenzae type b conjugate vaccine. Vaccine, 28 (43). pp. 7117-7122. ISSN 0264-410X DOI: 10.1016/j.vaccine.2010.07.074 Full text not available from this repository.

Pinder, M; Moorthy, VS; Akanmori, BD; Genton, B; Brown, GV; (2010) MALVAC 2009: progress and challenges in development of whole organism malaria vaccines for endemic countries, 3-4 June 2009, Dakar, Senegal. Vaccine, 28 (30). pp. 4695-702. ISSN 0264-410X DOI: 10.1016/j.vaccine.2010.04.091 Full text not available from this repository.

Russell, FM; Carapetis, JR; Balloch, A; Licciardi, PV; Jenney, AWJ; Tikoduadua, L; Waqatakirewa, L; Pryor, J; Nelson, J; Byrnes, GB; +3 more... (2010) Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial. Vaccine, 28 (19). pp. 3341-3349. ISSN 0264-410X DOI: 10.1016/j.vaccine.2010.02.087 Full text not available from this repository.

Russell, FM; Licciardi, PV; Balloch, A; Biaukula, V; Tikoduadua, L; Carapetis, JR; Nelson, J; Jenney, AW; Waqatakirewa, L; Colquhoun, S; +3 more... (2010) Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy. Vaccine, 28 (18). pp. 3086-94. ISSN 0264-410X DOI: 10.1016/j.vaccine.2010.02.065 Full text not available from this repository.

Van-Dunem, J; de Alencar, LCA; Rodrigues, LC; de Albuquerque, M; Ramos, ME; Ximenes, RAD; (2010) Sensitivity and specificity of BCG scar reading among HIV-infected children. Vaccine, 28 (9). pp. 2067-2069. ISSN 0264-410X DOI: 10.1016/j.vaccine.2009.12.034 Full text not available from this repository.

2009

Berthoud, TK; Fletcher, H; Porter, D; Thompson, F; Hill, AV; Todryk, SM; (2009) Comparing human T cell and NK cell responses in viral-based malaria vaccine trials. Vaccine, 28 (1). pp. 21-7. ISSN 0264-410X DOI: 10.1016/j.vaccine.2009.09.132 Full text not available from this repository.

Eisenhut, M; Paranjothy, S; Abubakar, I; Bracebridge, S; Lilley, M; Mulla, R; Lack, K; Chalkley, D; McEvoy, M; (2009) BCG vaccination reduces risk of infection with Mycobacterium tuberculosis as detected by gamma interferon release assay. Vaccine, 27 (44). pp. 6116-20. ISSN 0264-410X DOI: 10.1016/j.vaccine.2009.08.031 Full text not available from this repository.

Etuwewe, OM; Swann, N; Hollingshead, S; Tolmie, H; Zijlstra, EE; Faragher, B; French, N; Gordon, SB; (2009) Effect of recurrent invasive pneumococcal disease on serum anti-pneumolysin IgG titres in HIV infected adults. Vaccine, 27 (29). pp. 3881-4. ISSN 0264-410X DOI: 10.1016/j.vaccine.2009.04.026
[img]

Griffiths, UK; Korczak, VS; Ayalew, D; Yigzaw, A; (2009) Incremental system costs of introducing combined DTwP-hepatitis B-Hib vaccine into national immunization services in Ethiopia. Vaccine, 27 (9). pp. 1426-32. ISSN 0264-410X DOI: 10.1016/j.vaccine.2008.12.037 Full text not available from this repository.

Guzzetta, G; Manfredi, P; Gasparini, R; Panatto, D; Edmunds, WJ; (2009) On the relationship between meningococcal transmission dynamics and disease: Remarks on humoral immunity. Vaccine, 27 (25-26). pp. 3429-3434. ISSN 0264-410X DOI: 10.1016/j.vaccine.2009.01.092 Full text not available from this repository.

Jenney, A; Tikoduadua, L; Buadromo, E; Barnes, G; Kirkwood, CD; Boniface, K; Bines, J; Mulholland, K; Russell, F; (2009) The burden of hospitalised rotavirus infections in Fiji. Vaccine, 27. F108-F111. ISSN 0264-410X DOI: 10.1016/j.vaccine.2009.08.071 Full text not available from this repository.

Jit, M; Bilcke, J; Mangen, MJJ; Salo, H; Melliez, H; Edmunds, WJ; Yazdan, Y; Beutels, P; (2009) The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe. Vaccine, 27 (44). pp. 6121-6128. ISSN 0264-410X DOI: 10.1016/j.vaccine.2009.08.030 Full text not available from this repository.

Martin, A; Batty, A; Roberts, JA; Standaert, B; (2009) Cost-effectiveness of infant vaccination with RIX4414 (Rotarix (TM)) in the UK. Vaccine, 27 (33). pp. 4520-4528. ISSN 0264-410X DOI: 10.1016/j.vaccine.2009.05.006 Full text not available from this repository.

Moorthy, VS; Reed, Z; Smith, PG; (2009) MALVAC 2008: Measures of efficacy of malaria vaccines in phase 2b and phase 3 trials-Scientific, regulatory and public health perspectives. Vaccine, 27 (5). pp. 624-628. ISSN 0264-410X DOI: 10.1016/j.vaccine.2008.11.034 Full text not available from this repository.

Mulholland, K; Halsey, NA; Black, S; (2009) Developing sustainable funding for vaccine safety infrastructure. Vaccine, 28 (5). pp. 1133-4. ISSN 0264-410X DOI: 10.1016/j.vaccine.2009.11.034 Full text not available from this repository.

Noad, R; Roy, P; (2009) Bluetongue vaccines. Vaccine, 27. D86-D89. ISSN 0264-410X DOI: 10.1016/j.vaccine.2009.08.037 Full text not available from this repository.

Patel, MM; Clark, AD; Glass, RI; Greenberg, H; Tate, J; Santosham, M; Sanderson, CFB; Steele, D; Cortese, M; Parashar, UD; (2009) Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: Benefits of mortality reduction versus risk of fatal intussusception. Vaccine, 27 (22). pp. 2916-2922. ISSN 0264-410X DOI: 10.1016/j.vaccine.2009.03.016 Full text not available from this repository.

Russell, FM; Balloch, A; Tang, ML; Carapetis, JR; Licciardi, P; Nelson, J; Jenney, AW; Tikoduadua, L; Waqatakirewa, L; Pryor, J; +3 more... (2009) Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine. Vaccine, 27 (41). pp. 5685-91. ISSN 0264-410X DOI: 10.1016/j.vaccine.2009.06.098 Full text not available from this repository.

Stewart, M; Bhatia, Y; Athmaran, TN; Noad, R; Gastaldi, C; Dubois, E; Russo, P; Thi?ry, R; Sailleau, C; Br?ard, E; +2 more... (2009) Validation of a novel approach for the rapid production of immunogenic virus-like particles for bluetongue virus. Vaccine, 28 (17). pp. 3047-54. ISSN 0264-410X DOI: 10.1016/j.vaccine.2009.10.072 Full text not available from this repository.

Van Kerkhove, MD; Vong, S; Guitian, J; Holl, D; Mangtani, P; San, S; Ghani, AC; (2009) Poultry movement networks in Cambodia: Implications for surveillance and control of highly pathogenic avian influenza (HPAI/H5N1). Vaccine, 27 (45). pp. 6345-52. ISSN 0264-410X DOI: 10.1016/j.vaccine.2009.05.004 Full text not available from this repository.

Wagner, KS; Stickings, P; White, JM; Neal, S; Crowcroft, NS; Sesardic, D; Efstratiou, A; (2009) A review of the international issues surrounding the availability and demand for diphtheria antitoxin for therapeutic use. Vaccine, 28 (1). pp. 14-20. ISSN 0264-410X DOI: 10.1016/j.vaccine.2009.09.094 Full text not available from this repository.

Wright, V; Hibberd, M; Levin, M; (2009) Genetic polymorphisms in host response to meningococcal infection: the role of susceptibility and severity genes. Vaccine, 27 Suppl 2. B90-102. ISSN 0264-410X DOI: 10.1016/j.vaccine.2009.05.002 Full text not available from this repository.

van Kerkhove, MD; Vong, S; Guitian, J; Holl, D; Mangtani, P; San, S; Ghani, AC; (2009) Poultry movement networks in Cambodia: Implications for surveillance and control of highly pathogenic avian influenza (HPAI/H5N1). [Conference or Workshop Item] Full text not available from this repository.

2008

Agak, GW; Bejon, P; Fegan, G; Gicheru, N; Villard, V; Kajava, AV; Marsh, K; Corradin, G; (2008) Longitudinal analyses of immune responses to Plasmodium falciparum derived peptides corresponding to novel blood stage antigens in coastal Kenya. Vaccine, 26 (16). pp. 1963-1971. ISSN 0264-410X DOI: 10.1016/j.vaccine.2008.02.020 Full text not available from this repository.

Almonte, M; Albero, G; Molano, M; Carcamo, C; Garcia, PJ; Perez, G; (2008) Risk factors for Human Papillomavirus Exposure and Co-factors for Cervical Cancer in Latin America and the Caribbean. Vaccine, 26. L16-L36. ISSN 0264-410X DOI: 10.1016/j.vaccine.2008.06.008 Full text not available from this repository.

Bhutta, ZA; Haider, BA; Cousens, S; Black, RE; (2008) Response to "Conflicting evidence for neonatal vitamin A supplementation (letter)" by Benn et al. [Vaccine, 2008]. Vaccine, 26 (34). pp. 4304-4305. ISSN 0264-410X DOI: 10.1016/j.vaccine.2008.06.007 Full text not available from this repository.

Cooper, PA; Madhi, SA; Huebner, RE; Mbelle, N; Karim, SS; Kleinschmidt, I; Forrest, BD; Klugman, KP; (2008) Apnea and its possible relationship to immunization in ex-premature infants. Vaccine, 26 (27-28). pp. 3410-3. ISSN 0264-410X DOI: 10.1016/j.vaccine.2008.04.037 Full text not available from this repository.

Fletcher, HA; Pathan, AA; Berthoud, TK; Dunachie, SJ; Whelan, KT; Alder, NC; Sander, CR; Hill, AV; McShane, H; (2008) Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-beta1. Vaccine, 26 (41). pp. 5269-75. ISSN 0264-410X DOI: 10.1016/j.vaccine.2008.07.040
[img]

Gordon, SB; Malamba, R; Mthunthama, N; Jarman, ER; Jambo, K; Jere, K; Zijlstra, EE; Molyneux, ME; Dennis, J; French, N; (2008) Inhaled delivery of 23-valent pneumococcal polysaccharide vaccine does not result in enhanced pulmonary mucosal immunoglobulin responses. Vaccine, 26 (42). pp. 5400-5406. ISSN 0264-410X DOI: 10.1016/j.vaccine.2008.07.082
[img]

Herrero, R; Ferreccio, C; Salmeron, J; Almonte, M; Sanchez, GI; Lazcano-Ponce, E; Jeronimo, J; (2008) New Approaches to Cervical Cancer Screening in Latin America and the Caribbean. Vaccine, 26. L49-L58. ISSN 0264-410X DOI: 10.1016/j.vaccine.2008.05.025 Full text not available from this repository.

Murillo, R; Almonte, M; Pereira, A; Ferrer, E; Gamboa, OA; Jeronimo, J; Lazcano-Ponce, E; (2008) Cervical Cancer Screening Programs in Latin America and the Caribbean. Vaccine, 26. L37-L48. ISSN 0264-410X DOI: 10.1016/j.vaccine.2008.06.013 Full text not available from this repository.

Newton, S; Owusu-Agyei, S; Filteau, S; Gyan, T; Kirkwood, BR; (2008) Vitamin A supplements are well tolerated with the pentavalent vaccine. Vaccine, 26 (51). pp. 6608-13. ISSN 0264-410X DOI: 10.1016/j.vaccine.2008.09.037 Full text not available from this repository.

Noazin, S; Modabber, F; Khamesipour, A; Smith, PG; Moulton, LH; Nasseri, K; Sharifi, I; Khalil, EAG; Bernal, IDV; Antunes, CMF; +2 more... (2008) First generation leishmaniasis vaccines: A review of field efficacy trials. Vaccine, 26 (52). pp. 6759-6767. ISSN 0264-410X DOI: 10.1016/j.vaccine.2008.09.085 Full text not available from this repository.

Parkin, DM; Almonte, M; Bruni, L; Clifford, G; Curado, MP; Pineros, M; (2008) Burden and Trends of Type-Specific Human Papillomavirus Infections and Related Diseases in the Latin America and Caribbean Region. Vaccine, 26. L1-L15. ISSN 0264-410X DOI: 10.1016/j.vaccine.2008.05.043 Full text not available from this repository.

Saaka, M; Okoko, BJ; Kohberger, RC; Jaffar, S; Enwere, G; Biney, EE; Oluwalana, C; Vaughan, A; Zaman, SMA; Asthon, L; +4 more... (2008) Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The Gambia. Vaccine, 26 (29-30). pp. 3719-3726. ISSN 0264-410X DOI: 10.1016/j.vaccine.2008.04.066 Full text not available from this repository.

Sivaprakasam, V; Douglas, J; Selvaraj, S; MacIntyre, S; Carman, WF; (2008) The effectiveness of national influenza vaccination policies for at-risk populations over 5 seasons in a Scottish general practice. Vaccine, 26 (29-30). pp. 3772-7. ISSN 0264-410X DOI: 10.1016/j.vaccine.2008.04.030 Full text not available from this repository.

Trotter, CL; McVernon, J; Ramsay, ME; Whitney, CG; Mulholland, EK; Goldblatt, D; Hombach, J; Kieny, MP; SAGE subgroup; (2008) Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae. Vaccine, 26 (35). pp. 4434-45. ISSN 0264-410X DOI: 10.1016/j.vaccine.2008.05.073 Full text not available from this repository.

Vynnycky, E; Pitman, R; Siddiqui, R; Gay, N; Edmunds, WJ; (2008) Estimating the impact of childhood influenza vaccination programmes in England and Wales. Vaccine, 26 (41). pp. 5328-37. ISSN 0264-410X DOI: 10.1016/j.vaccine.2008.06.101 Full text not available from this repository.

2007

Aaby, P; Biai, S; Veirum, JE; Sodemann, M; Lisse, I; Garly, M.-, L; Ravn, H; Benn, CS; Rodrigues, A; (2007) DTP with or after measles vaccination is associated with increased in-hospital mortality in Guinea-Bissau. Vaccine, 25 (7). pp. 1265-1269. ISSN 0264-410X DOI: 10.1016/j.vaccine.2006.10.007 Full text not available from this repository.

Anh, DD; Canh, doG; Lopez, AL; Thiem, VD; Long, PT; Son, NH; Deen, J; von Seidlein, L; Carbis, R; Han, SH; +4 more... (2007) Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults. Vaccine, 25 (6). pp. 1149-55. ISSN 0264-410X DOI: 10.1016/j.vaccine.2006.09.049 Full text not available from this repository.

Aseffa, A; Bedru, A; Yamuah, L; Arga, D; Worku, A; Chandramohan, D; Nelson, CB; Engers, HD; (2007) Safety of a trivalent meningococcal ACW135 vaccine among young children in Ethiopia. Vaccine, 25. A79-A82. ISSN 0264-410X DOI: 10.1016/j.vaccine.2007.04.046 Full text not available from this repository.

Chandramohan, D; Hodgson, A; Coleman, P; Baiden, R; Asante, K; Awine, E; Owusu-Agyei, S; Boutriau, D; Nelson, CB; Greenwood, B; (2007) An evaluation of the immunogenicity and safety of a new trivalent meningococcal polysaccharide vaccine. Vaccine, 25S1. A83-A91. ISSN 0264-410X DOI: 10.1016/j.vaccine.2007.04.047 Full text not available from this repository.

Commander, NJ; Spencer, SA; Wren, BW; MacMillan, AP; (2007) The identification of two protective DNA vaccines from a panel of five plasmid constructs encoding Brucella melitensis 16M genes. Vaccine, 25 (1). pp. 43-54. ISSN 0264-410X DOI: 10.1016/j.vaccine.2006.07.046 Full text not available from this repository.

Cuevas, LE; Jeanne, I; Molesworth, A; Bell, M; Savory, EC; Connor, SJ; Thomson, MC; (2007) Risk mapping and early warning systems for the control of meningitis in Africa. Vaccine, 25 Suppl 1. A12-7. ISSN 0264-410X DOI: 10.1016/j.vaccine.2007.04.034 Full text not available from this repository.

Dilraj, A; Sukhoo, R; Cutts, FT; Bennett, JV; (2007) Aerosol and subcutaneous measles vaccine: Measles antibody responses 6 years after re-vaccination. Vaccine, 25 (21). pp. 4170-4174. ISSN 0264-410X DOI: 10.1016/j.vaccine.2007.03.003 Full text not available from this repository.

Duc, LH; Hong, HA; Atkins, HS; Flick-Smith, HC; Durrani, Z; Rijpkema, S; Titball, RW; Cutting, SM; (2007) Immunization against anthrax using Bacillus subtilis spores expressing the anthrax protective antigen. Vaccine, 25 (2). pp. 346-355. ISSN 0264-410X DOI: 10.1016/j.vaccine.2006.07.037 Full text not available from this repository.

Harris, JP; Jit, M; Cooper, D; Edmunds, WJ; (2007) Evaluating rotavirus vaccination in England and Wales. Part I. Estimating the burden of disease. Vaccine, 25 (20). pp. 3962-70. ISSN 0264-410X DOI: 10.1016/j.vaccine.2007.02.072 Full text not available from this repository.

Hermsen, CC; Verhage, DF; Telgt, DS; Teelen, K; Bousema, JT; Roestenberg, M; Bolad, A; Berzins, K; Corradin, G; Leroy, O; +2 more... (2007) Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial. Vaccine, 25 (15). pp. 2930-40. ISSN 0264-410X DOI: 10.1016/j.vaccine.2006.06.081 Full text not available from this repository.

Hesseling, AC; Cotton, MF; Marais, BJ; Gie, RP; Schaaf, HS; Beyers, N; Fine, PE; Abrams, EJ; Godfrey-Faussett, P; Kuhn, L; (2007) BCG and HIV reconsidered: Moving the research agenda forward. Vaccine, 25 (36). pp. 6565-8. ISSN 0264-410X DOI: 10.1016/j.vaccine.2007.06.045 Full text not available from this repository.

Lucas, ME; Jeuland, M; Deen, J; Lazaro, N; Macmahon, M; Nyamete, A; Barreto, A; von Seidlein, L; Cumbane, A; Songane, FF; +1 more... (2007) Private demand for cholera vaccines in Beira, Mozambique. Vaccine, 25 (14). pp. 2599-609. ISSN 0264-410X DOI: 10.1016/j.vaccine.2006.12.027 Full text not available from this repository.

Moore, SE; Jalil, F; Szu, SC; Hahn-Zoric, M; Prentice, AM; Hanson, LA; (2007) Revaccination does not improve an observed deficit in antibody responses in Pakistani adults born of a lower birth weight. Vaccine, 26 (2). pp. 158-65. ISSN 0264-410X DOI: 10.1016/j.vaccine.2007.11.007 Full text not available from this repository.

Moorthy, V; Reed, Z; Smith, PG; WHO Study Group on Measures of Malaria Vaccine Efficacy; (2007) Measurement of malaria vaccine efficacy in phase III trials: report of a WHO consultation. Vaccine, 25 (28). pp. 5115-23. ISSN 0264-410X DOI: 10.1016/j.vaccine.2007.01.085 Full text not available from this repository.

Murphy, D; Hull, L; Horn, O; Jones, M; Marteau, T; Hotopf, M; Rona, RJ; Wessely, S; (2007) Anthrax vaccination in a military population before the war in Iraq: side effects and informed choice. Vaccine, 25 (44). pp. 7641-8. ISSN 0264-410X DOI: 10.1016/j.vaccine.2007.08.065 Full text not available from this repository.

Newton, S; Owusu-Agyei, S; (2007) Need to worry: wrong vitamin A doses reported! Vaccine, 25 (23). p. 4514. ISSN 0264-410X DOI: 10.1016/j.vaccine.2007.01.002 Full text not available from this repository.

O'Sullivan, DM; Sander, C; Shorten, RJ; Gillespie, SH; Hill, AV; McHugh, TD; McShane, H; Tchilian, EZ; (2007) Evaluation of liquid culture for quantitation of Mycobacterium tuberculosis in murine models. Vaccine, 25 (49). pp. 8203-5. ISSN 0264-410X DOI: 10.1016/j.vaccine.2007.09.065 Full text not available from this repository.

Quarry, JE; Isherwood, KE; Michell, SL; Diaper, H; Titball, RW; Oyston, PCF; (2007) A Francisella tularensis subspecies novicida purF mutant, but not a purA mutant, induces protective immunity to tularemia in mice. Vaccine, 25 (11). pp. 2011-2018. ISSN 0264-410X DOI: 10.1016/j.vaccine.2006.11.054 Full text not available from this repository.

Riddell, A; Buttery, JP; McVernon, J; Chantler, T; Lane, L; Bowen-Morris, J; Diggle, L; Morris, R; Lockhart, S; Pollard, AJ; +2 more... (2007) A randomized study comparing the safety and immunogenicity of a conjugate vaccine combination containing meningococcal group C and pneumococcal capsular polysaccharide--CRM197 with a meningococcal group C conjugate vaccine in healthy infants: challenge phase. Vaccine, 25 (19). pp. 3906-12. ISSN 0264-410X DOI: 10.1016/j.vaccine.2007.01.097 Full text not available from this repository.

Rodrigues, LC; Kerr-Pontes, LR; Frietas, MV; Barreto, ML; (2007) Long lasting BCG protection against leprosy. Vaccine, 25 (39-40). pp. 6842-4. ISSN 0264-410X DOI: 10.1016/j.vaccine.2007.07.032 Full text not available from this repository.

Scott, JA; (2007) The preventable burden of pneumococcal disease in the developing world. Vaccine, 25 (13). pp. 2398-405. ISSN 0264-410X DOI: 10.1016/j.vaccine.2006.09.008 Full text not available from this repository.

Sirima, SB; Nebie, I; Ouedraogo, A; Tiono, AB; Konate, AT; Gansane, A; Derme, AI; Diarra, A; Ouedraogo, A; Soulama, I; +3 more... (2007) Safety and immtunogenicity of the Plasmodium falciparum merozoite surface protein-3 long synthethic peptide (MSP3-LSP) malaria vaccine in healthy, semi-immune adult males in Burkina Faso, West Africa. Vaccine, 25 (14). pp. 2723-2732. ISSN 0264-410X DOI: 10.1016/j.vaccine.2006.05.090 Full text not available from this repository.

Wang, XY; Xu, ZY; Ma, JC; von Seidlein, L; Zhang, Y; Hao, ZY; Han, OP; Zhang, YL; Tian, MY; Ouyang, PY; +4 more... (2007) Long-term immunogenicity after single and booster dose of a live attenuated hepatitis A vaccine: results from 8-year follow-up. Vaccine, 25 (3). pp. 446-9. ISSN 0264-410X DOI: 10.1016/j.vaccine.2006.08.004 Full text not available from this repository.

van der Sande, MAB; Mendy, M; Waight, P; Doherty, C; McConkey, SJ; Hall, AJ; Whittle, HC; (2007) Similar long-term vaccine efficacy of two versus three doses of HBV vaccine in early life. Vaccine, 25 (8). pp. 1509-1512. ISSN 0264-410X DOI: 10.1016/j.vaccine.2006.10.023 Full text not available from this repository.

2006

Aaby, P; Gustafson, P; Roth, A; Rodrigues, A; Fernandes, M; Sodemann, M; Holmgren, B; Benn, CS; Garly, M.-, L; Lisse, IM; +1 more... (2006) Vaccinia scars associated with better survival for adults. An observational study from Guinea-Bissau. Vaccine, 24 (29-30). pp. 5718-5725. ISSN 0264-410X DOI: 10.1016/j.vaccine.2006.04.045 Full text not available from this repository.

Al-Awaidy, S; Griffiths, UK; Nwar, HM; Bawikar, S; Al-Aisiri, MS; Khandekar, R; Mohammad, AJ; Robertson, SE; (2006) Costs of congenital rubella syndrome (CRS) in Oman: Evidence based on long-term follow-up of 43 children. Vaccine, 24 (40-41). pp. 6437-45. ISSN 0264-410X DOI: 10.1016/j.vaccine.2006.05.089 Full text not available from this repository.

Alonso, JM; Bertherat, E; Perea, W; Borrow, R; Chanteau, S; Cohet, C; Dodet, B; Greenwood, B; Laforce, FM; Rouzic, EML; +2 more... (2006) From genomics to surveillance, prevention and control: New challenges for the African meningitis belt. Vaccine, 24 (20). pp. 4279-4284. ISSN 0264-410X DOI: 10.1016/j.vaccine.2006.03.037 Full text not available from this repository.

Atkins, HS; Morton, M; Griffin, KF; Stokes, MGM; Nataro, JP; Titball, RW; (2006) Recombinant Salmonella vaccines for biodefence. Vaccine, 24 (15). pp. 2710-2717. ISSN 0264-410X DOI: 10.1016/j.vaccine.2005.12.046 Full text not available from this repository.

Cavailler, P; Lucas, M; Perroud, V; McChesney, M; Ampuero, S; Guerin, PJ; Legros, D; Nierle, T; Mahoudeau, C; Lab, B; +12 more... (2006) Feasibility of a mass vaccination campaign using a two-dose oral cholera vaccine in an urban cholera-endemic setting in Mozambique. Vaccine, 24 (22). pp. 4890-5. ISSN 0264-410X DOI: 10.1016/j.vaccine.2005.10.006 Full text not available from this repository.

Chen, X; Stanton, B; Wang, X; Nyamette, A; Pach, A; Kaljee, L; Pack, R; von Seidlein, L; Clemens, J; Gong, Y; +1 more... (2006) Differences in perception of dysentery and enteric fever and willingness to receive vaccines among rural residents in China. Vaccine, 24 (5). pp. 561-71. ISSN 0264-410X DOI: 10.1016/j.vaccine.2005.08.060 Full text not available from this repository.

Goncalves, G; Nascimento, MSJ; Reu, C; Cutts, FT; (2006) Levels of rubella antibody among vaccinated and unvaccinated Portuguese mothers and their newborns. Vaccine, 24 (49-50). pp. 7142-7147. ISSN 0264-410X DOI: 10.1016/j.vaccine.2006.06.062 Full text not available from this repository.

Griffiths, UK; Botham, L; Schoub, BD; (2006) The cost-effectiveness of alternative polio immunization policies in South Africa. Vaccine, 24 (29-30). pp. 5670-8. ISSN 0264-410X DOI: 10.1016/j.vaccine.2006.05.032 Full text not available from this repository.

Hartley, G; Taylor, R; Prior, J; Newstead, S; Hitchen, PG; Morris, HR; Dell, A; Titball, RW; (2006) Grey variants of the live vaccine strain of Francisella tularensis lack lipopolysaccharide O-antigen, show reduced ability to survive in macrophages and do not induce protective immunity in mice. Vaccine, 24 (7). pp. 989-996. ISSN 0264-410X DOI: 10.1016/j.vaccine.2005.08.075 Full text not available from this repository.

Hesseling, AC; Marais, BJ; Gie, RP; Schaaf, HS; Fine, PE; Godfrey-Faussett, P; Beyers, N; (2006) The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children. Vaccine, 25 (1). pp. 14-18. ISSN 0264-410X DOI: 10.1016/j.vaccine.2006.07.020 Full text not available from this repository.

Imoukhuede, EB; Berthoud, T; Milligan, P; Bojang, K; Ismaili, J; Keating, S; Nwakanma, D; Keita, S; Njie, F; Sowe, M; +7 more... (2006) Safety and immunogenicity of the malaria candidate vaccines FP9 CS and MVA CS in adult Gambian men. Vaccine, 24 (42-43). pp. 6526-33. ISSN 0264-410X DOI: 10.1016/j.vaccine.2006.06.022 Full text not available from this repository.

Joseph, C; Elgohari, S; Nichols, T; Verlander, N; (2006) Influenza vaccine uptake in adults aged 50-64 years: policy and practice in England 2003/2004. Vaccine, 24 (11). pp. 1786-91. ISSN 0264-410X DOI: 10.1016/j.vaccine.2005.10.024 Full text not available from this repository.

Lee, YC; Newport, MJ; Goetghebuer, T; Siegrist, CA; Weiss, HA; Pollard, AJ; Marchant, A; (2006) Influence of genetic and environmental factors on the immunogenicity of Hib vaccine in Gambian twins. Vaccine, 24 (25). pp. 5335-40. ISSN 0264-410X DOI: 10.1016/j.vaccine.2006.04.021 Full text not available from this repository.

Lehtinen, M; Herrero, R; Mayaud, P; Barnabas, R; Dillner, J; Paavonen, J; Smith, PG; (2006) Chapter 28: Studies to assess the long-term efficacy and effectiveness of HPV vaccination in developed and developing countries. Vaccine, 24 Suppl 3. S233-41. ISSN 0264-410X DOI: 10.1016/j.vaccine.2006.05.109 Full text not available from this repository.

Mulholland, K; (2006) Perspectives on the burden of pneumonia in children. Vaccine, 25 (13). pp. 2394-7. ISSN 0264-410X DOI: 10.1016/j.vaccine.2006.09.007 Full text not available from this repository.

Murphy, D; Dandeker, C; Horn, O; Hotopf, M; Hull, L; Jones, M; Marteau, T; Rona, R; Wessely, S; (2006) UK armed forces responses to an informed consent policy for anthrax vaccination: a paradoxical effect? Vaccine, 24 (16). pp. 3109-14. ISSN 0264-410X DOI: 10.1016/j.vaccine.2006.01.043 Full text not available from this repository.

Pack, R; Wang, Y; Singh, A; von Seidlein, L; Pach, A; Kaljee, L; Butraporn, P; Youlong, G; Blum, L; Bhutta, Z; +6 more... (2006) Willingness to be vaccinated against shigella and other forms of dysentery: a comparison of three regions in Asia. Vaccine, 24 (4). pp. 485-94. ISSN 0264-410X DOI: 10.1016/j.vaccine.2005.07.094 Full text not available from this repository.

Pinot de Moira, A; Edmunds, WJ; Breuer, J; (2006) The cost-effectiveness of antenatal varicella screening with post-partum vaccination of susceptibles. Vaccine, 24 (9). pp. 1298-307. ISSN 0264-410X DOI: 10.1016/j.vaccine.2005.09.028 Full text not available from this repository.

Platonov, AE; Griffiths, UK; Voeykova, MV; Platonova, OV; Shakhanina, IL; Chistyakova, GG; Robertson, SE; (2006) Economic evaluation of Haemophilus influenzae type b vaccination in Moscow, Russian Federation. Vaccine, 24 (13). pp. 2367-76. ISSN 0264-410X DOI: 10.1016/j.vaccine.2005.11.054 Full text not available from this repository.

Polley, SD; Conway, DJ; Cavanagh, DR; McBride, JS; Lowe, BS; Williams, TN; Mwangi, TW; Marsh, K; (2006) High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya. Vaccine, 24 (19). pp. 4233-46. ISSN 0264-410X DOI: 10.1016/j.vaccine.2005.06.030 Full text not available from this repository.

Rodrigues, A; Fischer, TK; Valentiner-Branth, P; Nielsen, J; Steinsland, H; Perch, M; Garly, M.-, L; Molbak, K; Aaby, P; (2006) Community cohort study of rotavirus and other enteropathogens: are routine vaccinations associated with sex-differential incidence rates? Vaccine, 24 (22). pp. 4737-4746. ISSN 0264-410X DOI: 10.1016/j.vaccine.2006.03.033 Full text not available from this repository.

Scott, FT; Johnson, RW; Leedham-Green, M; Davies, E; Edmunds, WJ; Breuer, J; (2006) The burden of Herpes Zoster: a prospective population based study. Vaccine, 24 (9). pp. 1308-14. ISSN 0264-410X DOI: 10.1016/j.vaccine.2005.09.026 Full text not available from this repository.

Sutton, AJ; Gay, NJ; Edmunds, WJ; (2006) Modelling the impact of prison vaccination on hepatitis B transmission within the injecting drug user population of England and Wales. Vaccine, 24 (13). pp. 2377-86. ISSN 0264-410X DOI: 10.1016/j.vaccine.2005.11.055 Full text not available from this repository.

Thiem, VD; Deen, JL; von Seidlein, L; Canh Do, G; Anh, DD; Park, JK; Ali, M; Danovaro-Holliday, MC; Son, ND; Hoa, NT; +2 more... (2006) Long-term effectiveness against cholera of oral killed whole-cell vaccine produced in Vietnam. Vaccine, 24 (20). pp. 4297-303. ISSN 0264-410X DOI: 10.1016/j.vaccine.2006.03.008 Full text not available from this repository.

Thornton, V; Lennon, D; Rasanathan, K; O'Hallahan, J; Oster, P; Stewart, J; Tilman, S; Aaberge, I; Feiring, B; Nokleby, H; +6 more... (2006) Safety and immunogenicity of New Zealand strain meningococcal serogroup B OMV vaccine in healthy adults: beginning of epidemic control. Vaccine, 24 (9). pp. 1395-400. ISSN 0264-410X DOI: 10.1016/j.vaccine.2005.09.043 Full text not available from this repository.

2005

Aaby, P; Rodrigues, A; Biai, S; Martins, C; Veirum, JE; Benn, CS; Jensen, H; (2005) Vaccines and unexpected observations: flaws or cause for concern? Vaccine, 23 (19). pp. 2407-2408. ISSN 0264-410X DOI: 10.1016/j.vaccine.2004.11.045 Full text not available from this repository.

Ameratunga, S; Macmillan, A; Stewart, J; Scott, D; Mulholland, K; Crengle, S; (2005) Evaluating the post-licensure effectiveness of a group B meningococcal vaccine in New Zealand: a multi-faceted strategy. Vaccine, 23 (17-18). pp. 2231-4. ISSN 0264-410X DOI: 10.1016/j.vaccine.2005.01.048 Full text not available from this repository.

Bojang, KA; Olodude, F; Pinder, M; Ofori-Anyinam, O; Vigneron, L; Fitzpatrick, S; Njie, F; Kassanga, A; Leach, A; Milman, J; +7 more... (2005) Safety and immunogenicty of RTS,S/AS02A candidate malaria vaccine in Gambian children. Vaccine, 23 (32). pp. 4148-57. ISSN 0264-410X DOI: 10.1016/j.vaccine.2005.03.019 Full text not available from this repository.

D'Ancona, F; Salmaso, S; Barale, A; Boccia, D; Lopalco, PL; Rizzo, C; Monaco, M; Massari, M; Demicheli, V; Pantosti, A; (2005) Incidence of vaccine preventable pneumococcal invasive infections and blood culture practices in Italy. Vaccine, 23 (19). pp. 2494-500. ISSN 0264-410X DOI: 10.1016/j.vaccine.2004.10.037 Full text not available from this repository.

Fitzsimons, D; Francois, G; Hall, A; McMahon, B; Meheus, A; Zanetti, A; Duval, B; Jilg, W; Bocher, WO; Lu, SN; +5 more... (2005) Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants. Vaccine, 23 (32). p. 4158. ISSN 0264-410X DOI: 10.1016/j.vaccine.2005.03.017 Full text not available from this repository.

Massad, E; Coutinho, FA; Burattini, MN; Lopez, LF; Struchiner, CJ; (2005) Yellow fever vaccination: How much is enough? Vaccine, 23 (30). pp. 3908-14. ISSN 0264-410X DOI: 10.1016/j.vaccine.2005.03.002 Full text not available from this repository.

O'Hallahan, J; Lennon, D; Oster, P; Lane, R; Reid, S; Mulholland, K; Stewart, J; Penney, L; Percival, T; Martin, D; (2005) From secondary prevention to primary prevention: a unique strategy that gives hope to a country ravaged by meningococcal disease. Vaccine, 23 (17-18). pp. 2197-201. ISSN 0264-410X DOI: 10.1016/j.vaccine.2005.01.061 Full text not available from this repository.

Oster, P; Lennon, D; O'Hallahan, J; Mulholland, K; Reid, S; Martin, D; (2005) MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain. Vaccine, 23 (17-18). pp. 2191-6. ISSN 0264-410X DOI: 10.1016/j.vaccine.2005.01.063 Full text not available from this repository.

Rafati, S; Nakhaee, A; Taheri, T; Taslimi, Y; Darabi, F; Eravani, D; Sanos, S; Kaye, P; Taghikhani, M; Jamshidi, S; +1 more... (2005) Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantum. Vaccine, 23 (28). pp. 3716-3725. ISSN 0264-410X DOI: 10.1016/j.vaccine.2005.02.009 Full text not available from this repository.

Roth, A; Sodemann, M; Jensen, H; Poulsen, A; Gustafson, P; Gomes, J; Djana, Q; Jakobsen, M; Garly, M.-, L; Rodrigues, A; +1 more... (2005) Vaccination technique, PPD reaction and BCG scarring in a cohort of children born in Guinea-Bissau 2000-2002. Vaccine, 23 (30). pp. 3991-3998. ISSN 0264-410X DOI: 10.1016/j.vaccine.2004.10.022 Full text not available from this repository.

2004

Aaby, P; Rodrigues, A; Biai, S; Martins, C; Veirum, JE; Benn, CS; Jensen, H; (2004) Oral polio vaccination and low case fatality at the paediatric ward in Bissau, Guinea-Bissau. Vaccine, 22 (23-24). pp. 3014-3017. ISSN 0264-410X DOI: 10.1016/j.vaccine.2004.02.009 Full text not available from this repository.

Collins, CL; Salt, P; McCarthy, N; Chantler, T; Lane, L; Hemme, F; Diggle, L; Buttery, J; Kitchin, NR; Moxon, ER; +1 more... (2004) Immunogenicity and safety of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine as a pre-school booster in UK children. Vaccine, 22 (31-32). pp. 4262-9. ISSN 0264-410X DOI: 10.1016/j.vaccine.2004.04.027 Full text not available from this repository.

Garmory, HS; Freeman, D; Brown, KA; Titball, RW; (2004) Protection against plague afforded by immunisation with DNA vaccines optimised for expression of the Yersinia pestis V antigen. Vaccine, 22 (8). pp. 947-957. ISSN 0264-410X DOI: 10.1016/j.vaccine.2003.09.020 Full text not available from this repository.

Hatzifoti, C; Bajaj-Elliott, M; Dorrell, N; Anyim, M; Prentice, MB; Nye, KE; Wren, B; Morrow, WJ; (2004) A plasmid immunization construct encoding urease B of Helicobacter pylori induces an antigen-specific antibody response and upregulates the expression of beta-defensins and IL-10 in the stomachs of immunized mice. Vaccine, 22 (20). pp. 2651-9. ISSN 0264-410X DOI: 10.1016/j.vaccine.2003.11.056 Full text not available from this repository.

Melegaro, A; Edmunds, WJ; (2004) Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales. Vaccine, 22 (31-32). pp. 4203-14. ISSN 0264-410X DOI: 10.1016/j.vaccine.2004.05.003 Full text not available from this repository.

Morton, M; Garmory, HS; Perkins, SD; O'Dowd, AM; Griffin, KF; Turner, AK; Bennett, AM; Titball, RW; (2004) A Salmonella enterica serovar Typhi vaccine expressing Yersinia pestis F1 antigen on its surface provides protection against plague in mice. Vaccine, 22 (20). p. 2524. ISSN 0264-410X DOI: 10.1016/j.vaccine.2004.01.007 Full text not available from this repository.

Ota, MOC; Vekemans, J; Schlegel-Haueter, SE; Fielding, K; Whittle, H; Lambert, PH; McAdam, Kpwj; Siegrist, CA; Marchant, A; (2004) Hepatitis B immunisation induces higher antibody and memory Th2 responses in new-borns than in adults. Vaccine, 22 (3-4). pp. 511-519. ISSN 0264-410X DOI: 10.1016/j.vaccine.2003.07.020 Full text not available from this repository.

Polley, SD; Mwangi, T; Kocken, CH; Thomas, AW; Dutta, S; Lanar, DE; Remarque, E; Ross, A; Williams, TN; Mwambingu, G; +3 more... (2004) Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria. Vaccine, 23 (5). pp. 718-28. ISSN 0264-410X DOI: 10.1016/j.vaccine.2004.05.031 Full text not available from this repository.

Scott, S; Mossong, J; Moss, WJ; Cutts, FT; Kasolo, F; Sinkala, M; Cousens, S; (2004) Estimating the force of measles virus infection from hospitalised cases in Lusaka, Zambia. Vaccine, 23 (6). pp. 732-8. ISSN 0264-410X DOI: 10.1016/j.vaccine.2004.07.026 Full text not available from this repository.

Stevens, W; Walker, D; (2004) Adolescent vaccination in the developing world: time for serious consideration? Vaccine, 22 (5-6). pp. 781-785. ISSN 0264-410X DOI: 10.1016/j.vaccine.2003.05.001 Full text not available from this repository.

de la Hoz, F; Higuera, AB; di Fabio, JL; Luna, M; Naranjo, AG; Valencia, MD; Pastor, D; Hall, AJ; (2004) Effectiveness of Haemophilus influenzae type b vaccination against bacterial pneumonia in Colombia. Vaccine, 23 (1). p. 36. ISSN 0264-410X DOI: 10.1016/j.vaccine.2004.05.017 Full text not available from this repository.

2003

Ali, M; Canh, DG; Clemens, JD; Park, JK; von Seidlein, L; Thiem, VD; Tho le, H; Trach, DD; (2003) The vaccine data link in Nha Trang, Vietnam: a progress report on the implementation of a database to detect adverse events related to vaccinations. Vaccine, 21 (15). pp. 1681-6. ISSN 0264-410X DOI: 10.1016/S0264-410X(02)00633-3 Full text not available from this repository.

Barbosa, T; Arruda, S; Fernandes, BD; Carvalho, LP; Cardoso, S; Cunha, S; Barreto, ML; Pereira, SM; Rodrigues, LC; Barral-Netto, M; (2003) BCG (Bacille of Calmette-Guerin) revaccination leads to improved in vitro IFN-gamma response to mycobacterial antigen independent of tuberculin sensitization in Brazilian school-age children. Vaccine, 21 (17-18). pp. 2152-2160. ISSN 0264-410X DOI: 10.1016/S0264-410X(02)00721-1 Full text not available from this repository.

Carabin, H; Edmunds, WJ; Gyldmark, M; Beutels, P; Levy-Bruhl, D; Salo, H; Griffiths, UK; (2003) The cost of measles in industrialised countries. Vaccine, 21 (27-30). pp. 4167-77. ISSN 0264-410X DOI: 10.1016/S0264-410X(03)00534-6 Full text not available from this repository.

Couper, KN; Nielsen, HV; Petersen, E; Roberts, F; Roberts, CW; Alexander, J; (2003) DNA vaccination with the immunodominant tachyzoite surface antigen (SAG-1) protects against adult acquired Toxoplasma gondii infection but does not prevent maternofoetal transmission. Vaccine, 21 (21-22). pp. 2813-20. ISSN 0264-410X DOI: 10.1016/S0264-410X(03)00163-4 Full text not available from this repository.

Filteau, S; (2003) The influence of mastitis on antibody transfer to infants through breast milk. Vaccine, 21 (24). pp. 3377-81. ISSN 0264-410X DOI: 10.1016/S0264-410X(03)00337-2 Full text not available from this repository.

Foynes, S; Holley, JL; Garmory, HS; Titball, RW; Fairweather, NF; (2003) Vaccination against type F botulinum toxin using attenuated Salmonella enterica var Typhimurium strains expressing the BoNT/F HC fragment. Vaccine, 21 (11-12). pp. 1052-1059. ISSN 0264-410X DOI: 10.1016/S0264-410X(02)00622-9 Full text not available from this repository.

Garmory, HS; Griffin, KF; Brown, KA; Titball, RW; (2003) Oral immunisation with live aroA attenuated Salmonella enterica serovar Typhimurium expressing the Yersinia pestis V antigen protects mice against plague. Vaccine, 21 (21-22). pp. 3051-3057. ISSN 0264-410X DOI: 10.1016/s0264-410x(03)00112-9 Full text not available from this repository.

Greenwood, B; (2003) Maternal immunisation in developing countries. Vaccine, 21 (24). pp. 3436-41. ISSN 0264-410X DOI: 10.1016/s0264-410x(03)00346-3 Full text not available from this repository.

Iqbal, M; Lin, W; Jabbal-Gill, I; Davis, SS; Steward, MW; Illum, L; (2003) Nasal delivery of chitosan-DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice. Vaccine, 21 (13-14). pp. 1478-85. ISSN 0264-410X DOI: 10.1016/S0264-410X(02)00662-X Full text not available from this repository.

Vynnycky, E; Gay, NJ; Cutts, FT; (2003) The predicted impact of private sector MMR vaccination on the burden of Congenital Rubella Syndrome. Vaccine, 21 (21-22). pp. 2708-2719. ISSN 0264-410X DOI: 10.1016/S0264-410X(03)00229-9 Full text not available from this repository.

2002

Acharya, A; Diaz-Ortega, JL; Tambini, G; de Quadros, C; Arita, I; (2002) Cost-effectiveness of measles elimination in Latin America and the Caribbean: a prospective analysis. Vaccine, 20 (27-28). pp. 3332-41. ISSN 0264-410X DOI: 10.1016/S0264-410X(02)00296-7 Full text not available from this repository.

Brisson, M; Edmunds, WJ; (2002) The cost-effectiveness of varicella vaccination in Canada. Vaccine, 20 (7-8). pp. 1113-25. ISSN 0264-410X DOI: 10.1016/S0264-410X(01)00437-6 Full text not available from this repository.

Brisson, M; Gay, NJ; Edmunds, WJ; Andrews, NJ; (2002) Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine, 20 (19-20). pp. 2500-7. ISSN 0264-410X DOI: 10.1016/S0264-410X(02)00180-9 Full text not available from this repository.

Edmunds, WJ; Brisson, M; Melegaro, A; Gay, NJ; (2002) The potential cost-effectiveness of acellular pertussis booster vaccination in England and Wales. Vaccine, 20 (9-10). pp. 1316-30. ISSN 0264-410X DOI: 10.1016/S0264-410X(01)00473-X Full text not available from this repository.

Garmory, HS; Griffin, KF; Leary, SEC; Perkins, SD; Brown, KA; Titball, RW; (2002) The effect of recombinant plasmids on in vivo colonisation of Salmonella enterica serovar Typhimurium strains is not reflected by in vitro cellular invasion assays. Vaccine, 20 (27-28). pp. 3239-43. ISSN 0264-410X DOI: 10.1016/S0264-410X(02)00292-X Full text not available from this repository.

Ghosh, MK; Deriaud, E; Saron, MF; lo-Man, R; Henry, T; Jiao, X; Roy, P; Leclerc, C; (2002) Induction of protective antiviral cytotoxic T cells by a tubular structure capable of carrying large foreign sequences. Vaccine, 20 (9-10). pp. 1369-77. ISSN 0264-410X DOI: 10.1016/S0264-410X(01)00467-4 Full text not available from this repository.

Ghosh, MK; LI, CL; Fayolle, C; Dadaglio, G; Murphy, A; Lemonnier, FA; Roy, P; Leclerc, C; (2002) Induction of HLA-A2-restricted CTL responses by a tubular structure carrying human melanoma epitopes. Vaccine, 20 (19-20). pp. 2463-73. ISSN 0264-410X DOI: 10.1016/S0264-410X(02)00185-8 Full text not available from this repository.

Hasan, UA; Harper, DR; Wren, BW; Morrow, WJ; (2002) Immunization with a DNA vaccine expressing a truncated form of varicella zoster virus glycoprotein E. Vaccine, 20 (9-10). pp. 1308-15. ISSN 0264-410X DOI: 10.1016/S0264-410X(01)00475-3 Full text not available from this repository.

Shi, FH; Zhang, YB; Lin, JJ; Zuo, X; Shen, W; Cai, YM; Ye, P; Bickle, QD; Taylor, MG; (2002) Field testing of Schistosoma japonicum DNA vaccines in cattle in China. Vaccine, 20 (31-32). pp. 3629-31. ISSN 0264-410X DOI: 10.1016/S0264-410X(02)00398-5 Full text not available from this repository.

Smeeth, L; Rodrigues, LC; Hall, AJ; Fombonne, E; Smith, PG; (2002) Evaluation of adverse effects of vaccines: the case-control approach. Vaccine, 20 (19-20). pp. 2611-7. ISSN 0264-410X DOI: 10.1016/S0264-410X(02)00147-0 Full text not available from this repository.

da Cunha, SS; Rodrigues, LC; Barreto, ML; Dourado, I; (2002) Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad-Zagreb mumps strain. Vaccine, 20 (7-8). pp. 1106-12. ISSN 0264-410X DOI: 10.1016/S0264-410X(01)00438-8 Full text not available from this repository.

2001

Edmunds, WJ; Brisson, M; Rose, JD; (2001) The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales. Vaccine, 19 (23-24). pp. 3076-90. ISSN 0264-410X DOI: 10.1016/S0264-410X(01)00044-5 Full text not available from this repository.

Edmunds, WJ; Gay, NJ; Henao Restrepo, AM; Olive, JM; Bele, O; (2001) Measles vaccination in Africa: by how much could routine coverage be improved? Vaccine, 20 (1-2). pp. 16-8. ISSN 0264-410X DOI: 10.1016/S0264-410X(01)00264-X Full text not available from this repository.

Schnorr, JJ; Cutts, FT; Wheeler, JG; Akramuzzaman, SM; Alam, MS; Azim, T; Schneider-Schaulies, S; Ter-Meulen, V; (2001) Immune modulation after measles vaccination of 6-9 months old Bangladeshi infants. Vaccine, 19 (11-12). pp. 1503-10. ISSN 0264-410X Full text not available from this repository.

Shi, FH; Zhang, YB; Ye, P; Lin, JJ; Cai, YM; Shen, W; Bickle, QD; Taylor, MG; (2001) Laboratory and field evaluation of Schistosoma japonicum DNA vaccines in sheep and water buffalo in China. Vaccine, 20 (3-4). pp. 462-467. ISSN 0264-410X DOI: 10.1016/S0264-410X(01)00340-1 Full text not available from this repository.

This list was generated on Sun Jun 25 08:36:12 2017 BST.